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Abstract 
The Bacillus cereus group of bacteria is a subgroup in the Bacillus genus and consists of six 
different species. Research has evolved mainly around B. cereus, B. thuringiensis and B. 
anthracis, an opportunistic pathogen capable of food poisoning and infections in mammals, 
an insecticidal pathogen which can also be an opportunistic pathogen in mammals, and an 
opportunistic pathogen capable of causing cutaneous and or/systemic anthrax in mammals, 
respectively. These species are closely related based on analysis of chromosomal markers, 
but pathogenicity patterns vary mainly due to virulence factors carried on plasmids. 
Taxonomic differentiation has been, and continues to be, difficult, as many features used to 
classify the organisms are plasmid-borne. 
Several studies have shown that many strains in the B. cereus group are capable of producing 
biofilms, multicellular aggregates of cells that may contribute to virulence, antibiotic 
resistance and to reservoirs forming in food production facilities and hospitals. B. cereus, 
ubiquitously found as spores in soil, has been implicated in several cases of food spoilage. 
Research of biofilm formation in B. cereus is, therefore, important for economic and health- 
related purposes. 
One research group reported in 2008 that two c-di-GMP responsive riboswitches, non- 
translated regions of mRNA located at the 5’-end that may govern further expression of a 
downstream gene, had been identified in Bacillus cereus strains ATCC 14579 and ATCC 
10987. Sequence searches based on the sequences of these riboswitches showed that two 
similar riboswitches were present in B. thuringiensis 407, and two genes were located 
downstream of these riboswitches, whose proteins contained domains typical of cell surface 
adhesion (Bt407_1060) and chemotaxis (Bt407_0422) proteins, respectively. As c-di-GMP 
is an important regulator of biofilm formation in gram-negative bacteria, it was decided to 
proceed with functional studies of these two proteins. The aim of this thesis was to expand 
on initial research performed on this topic in the group. 
The functional studies performed in this thesis confirmed that a gene deletion in Bt407_1060 
(cell surface adhesion protein) resulted in reduced biofilm formation in a microtiter plate 
screening assay. Previous studies on adhesion proteins in gram-positive bacteria have shown  
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an effect on biofilm formation when genes encoding the adhesion proteins were removed. No 
effect was observed on biofilm formation in a screening of the Bt407_0422 (methyl-
accepting chemotaxis protein) gene deletion mutant compared to wildtype. Previous research 
in other bacteria has deemed chemotaxis as non-essential to biofilm formation, as opposed to 
the presence of flagella or motile behaviour, which seems of importance. However, in order 
to ratify these results, complementation and overexpression of the genes would be necessary. 
Future research should also focus on the role of c-di-GMP in the regulation of biofilm 
formation by B. cereus group bacteria to enhance our understanding of c-di-GMP regulated 
processes in gram-positive bacteria. 
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Chapter 1: Introduction  
1.1 The Bacillus genus 
 
The Bacillus genus is in the family Bacillaceae and consists of rod-shaped, gram-positive, 
aerobe/facultative anaerobic, spore-forming bacteria. The natural habitat ranges from soil and 
vegetation to insect intestines, and some species are pathogenic to insects and/or 
animals/mammals while most are considered non- pathogenic.  
The vegetative cells range from 0.5 by 1.2 to 2.5 by 10 µm in diameter and can grow at 
optimal temperatures ranging from 25 to 37°C, although thermophilic and psychrophilic 
members are capable of growth at temperatures as high as 75°C or as low as 3°C [6]. The 
members of the genus may grow at a variety of pH values ranging from 2 to 10 [6]. The G+C 
content of the DNA of species within the genus can vary from 32 to 69%. Most strains are 
catalase positive, possess peritrichous flagella, and sporulate in air, differentiating members 
of this genus from the clostridia [6]. 
1.1.1 Bacillus cereus group 
 
The B. cereus group is a subgroup within the Bacillus genus, and consists of several species, 
all which are closely related and some share very similar chromosomal content. The species 
included in the group are B. cereus, B. anthracis, B. thuringiensis, B. mycoides, B. 
pseudomycoides and B. weihenstephanensis. The first three species are considered 
opportunistic pathogens in mammals and insects while the last three species are generally 
considered non- pathogenic [7]. In addition, a strain in the B. cereus group, Bacillus cereus 
subsp. cytotoxis, is also important, as it has been implicated in severe cases of food  
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poisoning leading to human death, and belongs to a phylogenetically remote subgroup of  
thermotolerant isolates [8]. 
Based on chromosomal phylogeny, the B. cereus group has been suggested to comprise 
variations of the same species, but with distinct phenotypic differences. Some scientists have 
suggested that they are all members of a single species, B. cereus sensu lato [9]. 
1.1.2 Genomics of the Bacillus cereus group 
 
It has been difficult to establish a commonly accepted taxonomic classification between the 
species in the Bacillus cereus group. Several techniques, including PCR patterns [10], multi-
locus enzyme electrophoresis [11], ribotyping [12] and carbohydrate profiles [13] have been 
employed in order to try to differentiate between different species in the B. cereus group. 
Additionally, DNA–DNA hybridization  and comparison of 16S or 23S rRNA sequences or 
16S–23S rRNA [9], have also been used.  
 
Phenotypic traits have been used to distinguish B. anthracis from other Bacillus species in 
the lab due to a nonsense point mutation in the global transcriptional translator PlcR which 
results in no or severely reduced activity of PlcR- regulated genes within the bacteria [14]. 
These difference include being non-motile, non-hemolytic, negative for phospholipase C 
(PLC) production, and sensitive to γ phage [7]. 
 
Genes located on plasmids account for much of the differences in pathogenicity observed 
between B. cereus, B. anthracis and B. thuringiensis. A strain designated as B. cereus 
(Bacillus cereus G9241) has been found to contain two plasmids, one plasmid which closely 
resembles the pXO1 plasmid found in B. anthracis and a second plasmid carrying genes 
coding for a polysaccharide capsule. This particular strain caused a disease resembling 
anthrax in American patients [15]. B. cereus strains isolated from dead chimpanzees in 
Africa have been shown to contain plasmids which closely resemble pXO1 and pXO2 [7, 
16]. These cases where the plasmids have been shown to be able to transfer between  
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different cells and strains have made characterization by plasmid content non- satisfactory. B. 
thuringiensis strains cured of their plasmids are indistinguishable from B. cereus. Several 
researchers have concluded that these three species share the same ancestor, and has 
successfully developed into an individual lineage.  
 
1.2 Strains of the Bacillus cereus group 
 
1.2.1 Bacillus cereus 
 
Bacillus cereus is considered an opportunistic pathogen in animals and mammals. Most B. 
cereus strains are motile (flagella), form wide, opaque, irregular colonies when grown on 
solid surface mediums and utilize glucose as the main carbon source [17]. 
 
The B. cereus endosymbiotic life cycle consist of three distinct 
phases. B. cereus is ubiquitously found as spores in soil, but 
spores are able to germinate and colonize the gastro-intestinal 
system in mammals and in insects [5] and other organic matter 
.Vegetative cells sporulate upon depletion of nutrients and other 
environmental signals and return to the soil. There has been 
dispute whether the life cycle in B. cereus is pathogenic or not 
[5]. 
 
Alternatively, B. cereus may establish an infection in mammalian tissue where it may cause 
severe infections, including non- gastrointestinal infections (eye, respiratory tract and 
nosocomial infections in hospitals) and gastrointestinal infections where it may cause food 
poisoning [6]. 
Figure 1: Life cycle of 
Bacillus cereus (figure 
from Jensen et. al [5]) 
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The food poisoning capabilities of B. cereus, reviewed by Stenfors Arnesen et al. [8], is due 
to synthesis of specific toxins. The emetic type of food poisoning is caused by a 
dodecadepsipeptide, cereulide, while the diarrheal type is linked to three different toxins, 
haemolysin BL (Hbl), nonhaemolytic enterotoxin (Nhe) and cytotoxin K (cytK).  
 
B. cereus is regarded as one of the most common organisms that impair the quality of dairy 
products [18], and it is hypothesised that the highly adhesive properties of the B. cereus 
endospores are the main cause, leading to adherence of the bacterium to milk tanks and other 
food processing equipment,  in combination with the ability of some strains to form stable 
biofilms at several different surfaces and under different conditions [19]. B. cereus carries 
several plasmids, but the function of these is not fully understood.  
 
1.2.2 Bacillus thuringiensis 
 
Bacillus thuringiensis is a ubiquitous bacterium deposited in the soil and which produces 
insecticidal δ-  endotoxins during sporulation [20] , hence its application as a biopesticide 
[21]. The toxins may contribute up to 25% of the total mass of the sporulated cells [22]. The 
genes encoding these toxins are located on large transferable plasmids, the loss of which 
makes B. thuringiensis indistinguishable to B. cereus [7]. B. thuringiensis carries the same 
chromosomal toxin genes as B. cereus, and may cause disease such as food poisoning [23].  
Briefly, the life cycle of B. thuringiensis, consists of spores deposited in the soil, but 
introduction to the gut of earthworms, leather jacket larvae and plant rhizospheres result in 
germination and proliferation. Upon host death, the vegetative cells sporulate and return to 
the soil [5]. It has been speculated that insect larvae are the natural habitat for both B. 
thuringiensis and B. cereus [5].  
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1.2.3 Bacillus anthracis 
 
Bacillus anthracis is the causative agent of anthrax disease in 
humans and animals, and has been identified sporadically 
worldwide. B. anthracis normally exists as a dormant spore in 
soil, but is capable of infecting most mammals. During the 
infection process, B. anthracis germinates, causing local 
infection of skin lesions (cutaneous anthrax), gastrointestinal 
infection or systemic anthrax through inhalation. The latter is 
the most severe form of disease, and is the main reason B. 
anthracis has become somewhat infamous due to its application 
as biochemical weapon. Upon host death, the spores are released 
back into the soil, completing the life cycle (figure 2) [5]. 
B. anthracis strains contain two large plasmids, pXO1 and pXO2, which contain virulence 
factors such as toxin and capsule genes, respectively. pXO1 encodes three different toxins; 
protective antigen (PA), lethal factor (LF) and oedema factor (EF), while plasmid pXO2 
encodes a poly- D glutamic acid capsule which is important for pathogenicity; as it enables 
the bacterium to evade detection by the immune system in the infected host [5]. Loss of 
pX02 results in severely decreased ability to establish an infection, and is the basis for the 
attenuated vaccine with the avirulent strain B. anthracis Sterne [5]. 
 
 
 
 
 
Figure 2: Life cycle of B. 
anthracis. Figure taken 
from Jensen et al. [5] 
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1.2.4 B. mycoides 
 
Strains of B. mycoides were initially differentiated from B. cereus and B. thuringiensis by its 
non-motile behaviour and ability to form rhizoidal colonies. Comparison of DNA relatedness 
between the B. mycoides type strain NRRL NRS- 273 and selected strains of B. cereus, B. 
thuringiensis, and other strains of B. mycoides ranged from 24 to 34%, from 29 to 37%, and 
from 20 to l00% [24]. This study concluded that B. mycoides are not closely related to B. 
cereus and B. thuringiensis, therefore arguing for distinction as a separate species. Further 
analysis revealed that B. mycoides strains could be categorized into two groups, since then 
one of these groups has been classified as an independent species in the B. cereus group, B. 
pseudomycoides (1.2.5). These two groups were differentiated mainly based on their 
different fatty acid composition [24, 25]. 
 
 
1.2.5 Bacillus pseudomycoides  
 
B. pseudomycoides was initially classified as a subgroup of B. mycoides, with approximately 
98% identity in 16S rRNA sequences [25]. Studies of fatty acid composition [24], however, 
revealed differences in 12:0 iso, and 13:0 anteiso fatty acids. These results suggested a new 
species in the Bacillus group.  
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1.2.6 Bacillus weihenstephanensis 
 
A sixth species in the B. cereus group was proposed in 1998 [26], Bacillus 
weihenstephanensis which consist of psychrotolerant isolates. This was based on specific 
sequence differences in 16S rDNA and 23S rDNA, as well as in the16S-23S rDNA spacer 
region and the structural genes encoding the major cold- shock protein homologue cspA 
relative to mesophilic and psychrotolerant strains previously identified as B. cereus or B. 
mycoides. The type strain, WSBC 10 204T, can be differentiated from B. cereus by growth at 
7°C or lower, no growth at 43°C and specific sequences in 16S rRNA and cspA genes. B. 
weihenstephanensis is considered a potential pathogen [26]. 
 
1.2.7 Bacillus cereus subsp. cytotoxis 
 
The Bacillus cereus strain NVH391-98, later suggested as Bacillus cereus subsp. cytotoxis, 
was, after sequence analysis revealed several differences in gene regulation from other 
members of the Bacillus cereus group, proposed as a new species, Bacillus cytotoxicus [27]. 
The status as a novel species is yet to be approved. The strain was discovered after a serious 
food poisoning outbreak [28] and sequence analysis showed that the strain lacked σB, which 
is unique to spore- forming Bacillus strains, contained no tryptophan synthesis genes and 
contained genes implicated in biosynthesis of a food-poisoning toxin, cytotoxin K, which has 
been postulated to constitute the main virulence factor [27, 29]. Later it has been discovered 
that many B. cereus group strains carry the cytK gene, and that the severe toxicity of the 
NVH391-98 strain is probably due to high production of the cytK cytotoxin [30].  
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1.3 Biofilm 
 
1.3.1 Biofilm formation 
 
Biofilms are multicellular aggregates or communities of microorganisms attached to a 
surface [31]. Biofilms have some general properties; they usually contain an extracellular 
matrix consisting of an extracellular polysaccharide (EPS), nucleic acids and/or proteins. 
Also, biofilm formation is triggered as a response to extracellular signals from the 
environment and may provide protection from antibiotics, predators and components of the 
immune system inside a host [32].  
Biofilms may be mono-, bi- or multilayered and have complex three- dimensional structures 
(figure 3) [32]. Monolayer formation dominates when cell-surface interaction is more 
prevalent than cell- cell interaction and vice versa. Biofilms can form on environmental 
abiotic surfaces such as minerals, on the carapaces of dead organisms, or at air-water 
interfaces. They can also form on biotic surfaces in the natural environment, such as plants, 
other microbes, and animals.  
 
Figure 3: Left figure shows a monolayer biofilm attached to a surface, while 
two clusters (multilayer) of bacteria attached to a surface can be seen on the 
right. Multilayer biofilms are comprised of cells and an extracellular matrix 
with proteins, exopolysaccharides and/or nucleic acids (figure taken from 
Karatan et. al [31]). 
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The general model for biofilm formation is different for motile and non- motile bacteria [32]. 
Non- motile bacteria usually initiate their biofilm formation through individual cells starting 
to produce surface adhesins. This promotes cell- to- cell interaction that is important for 
attaching to a surface and to other bacteria [32]. Other important components for the biofilm 
formation, exopolysaccharides (EPS) in particular, are also produced early in the process.  
Motile bacteria are able to move close to a surface and undergo several changes. The cells 
may switch from expressing genes important for motility (e.g. flagella) to produce 
components important for biofilm formation such as matrix proteins and EPS [32, 33]. Early 
in the process, motility has been shown to be very important for the ability of these cells to 
produce a biofilm. 
Lemon et. al [32] states that motile bacteria develop biofilm in five distinct phases: 
1. Bacteria relocate/adhere to a surface 
2. Monolayer formation 
3. Multilayer formation (multiple colonies in layers) 
4. Extracellular matrix production 
5. Biofilm stabilisation  
 
Just as bacteria might form a biofilm, and thereby adapt to a non- motile lifestyle, they may 
also disperse from the biofilm and return to a motile lifestyle when this is favourable (e.g. 
during depletion of nutrients or accumulation of toxic products due to high cell densities) 
[31].  
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1.3.2 Biofilm formation in B. cereus and B. subtilis 
 
Several strains of Bacillus cereus have been shown to constitute biofilm production in low- 
nutrition media [18]. B. cereus biofilm formation has been observed on plastic, glass wool, 
and stainless steel, materials which have all been utilized for in vitro research on B. cereus 
biofilm formation [34-36]. The extracellular components making up the biofilm produced by 
B. cereus have not been heavily investigated, however, extracellular DNA (eDNA) has been 
shown to be a necessary component in B. cereus biofilms [37]. This is not unexpected since 
most characterized biofilms studied in other bacteria include exopolysaccharides, proteins 
and eDNA. eDNA has been observed in biofilms produced by other gram positive bacteria 
such as Staphylococcus aureus [38]. 
Bacillus subtilis, a model species for gram-positive bacteria, have been extensively studied 
for its biofilm and sporulation capabilities. B. subtilis tends to form pellicles of cells at the 
air- liquid interface in standing cultures after reaching a certain cell density [32]. Aerial 
projections formed after 5+ days of growth have been shown to be the preferential site of 
spore formation, on the basis of high expression of the gene sspE which has been shown to 
be expressed late in the sporulation process [39]. Characterization of biofilms produced by 
the natural wildtype B. subtilis strain 3610 showed that eps (genes responsible for 
exopolysaccharide production/tasA (gene responsible for production of the matrix protein 
TasA) mutants were not able to produce a proper biofilm [40]. This study underlined the 
importance of exopolysaccharides and TasA as matrix components.  
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1.3.3 Regulation of biofilm formation  
 
Regulation of biofilm formation is highly complex and varies between different species of 
bacteria. A broad overview is given in a review by Karatan concerning research on biofilm 
formation and regulation in vitro [31], with an emphasis on the development of multilayer 
biofilms. Regulation was split into seven categories; mechanical signals, nutritional and 
metabolic cues, inorganic molecules, osmolarity, host- derived signals, antimicrobials and 
quorum signals.  
 
Mechanical signals; there are some evidence that bacteria are able to sense and initiate 
lifestyle changes/biofilm formation in close proximity to surfaces. The flagellar motor 
system has been identified as one possible regulator of this process since defective flagella in 
mutant strains results in less biofilm formation in vitro for the motile bacterium Vibrio 
cholerae [41].  
 
Nutritional and metabolic cues; observations and studies of biofilm formation in vitro have 
shown that the growth medium, especially the amount of nutrition, e.g.  glucose levels have 
an effect on biofilm formation. Some species, such as V. cholerae, may initiate biofilm 
formation in environments with high concentration of glucose [42] while other species 
repress biofilm formation [43-45]. Catabolite repression (utilization of one carbon source at a 
time, preferably glucose) has also been shown to affect biofilm formation for several species.  
 
Inorganic molecules; levels of iron and phosphate in the environment surrounding the 
bacteria have both been shown to affect biofilm formation for some species such as 
Pseudomonas aeruginosa and Pseudomonas fluorescens, respectively [46, 47].  
 
Osmolarity; increased levels of salt and/or sucrose in growth medium has been shown to 
inhibit biofilm formation in P.fluorescens [48]. Salt levels has, indirectly, proven to affect 
expression and activity of several biofilm-related genes [31].  
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Host- derived signals; defense mechanisms of the host, such as bile acids and hydrogen 
peroxide secretion, may promote biofilm formation in V. cholerae and P.  aeruginosa, 
respectively [49, 50]. 
 
Antimicrobials; several studies have shown that some species alter biofilm formation when 
antibiotics are present, and that biofilms might explain the elevated antibiotic resistance 
observed by some bacteria [51]. 
 
Quorom signals; quorum sensing is a signal system which enables the bacterium to change 
its metabolism in response to extracellular events such as high cell density or the presence of 
other species of bacteria. Most gram-negative bacteria have been shown to possess a system 
similar to the LuxI/LuxR system [52] while gram positive bacteria usually have a system 
where a species-specific autoinducing peptide is processed, pumped out of the cell and bind 
sensor kinases which phosphorylate response regulator proteins and thereby affect gene 
expression [52]. It has been shown that several species change biofilm formation in response 
to changes in cell density, such as V. cholerae, S. aureus, P. aeruginosa [31] and B. cereus 
[34].  
 
1.3.4 Regulation of biofilm formation in B. cereus and B. subtilis 
 
The regulation of biofilm in Bacillus cereus is not fully elucidated. More research has, 
however, been done on the model species Bacillus subtilis. Over the years, researchers have 
been able to identify some key genes and regulatory systems which affect biofilm formation.  
Studies of B. subtilis, which is related to B. cereus,  show that biofilm formation 
predominates in low glucose environments [53], which is known to affect the positive 
transcription regulator Spo0A, probably due to metabolism of glucose to acetoin [54].  
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Spo0A is known to regulate the transcription factors SinI and SinR (often referred to as the 
master regulators for the switch between motile, vegetative and non-motile, sedentary 
behavior). SinI/SinR regulate the expression of two operons, EpsA-O (important for 
production of EPS) and yqxM-sipW-tasA (three genes which code for two secreted matrix 
proteins), which are important for biofilm formation (see figure 4) [55]. It was shown that 
sinI expression varies considerably within cells in a biofilm. This has led to a discussion 
whether the matrix produced in a biofilm is produced by all cells to some degree or if a 
subgroup of cells produce matrix components while most cells do not [56]. The possibility of 
such a division has been ratified by in vitro studies done on other bacteria such as V. 
cholerae [57]. In this study, mixtures of biofilm positive and negative cells were able to 
produce biofilms with 10% or less biofilm positive cells.  
 
Figure 4: The regulation of expression of genes in B. subtilis by the bistable 
regulator Spo0A. When Spo0A is activated, SinI, the repressor of SinR, is 
expressed. SinI alleviate SinR repression of several operons, eps, which 
produce extracellular polysaccharides, and yqxm-sipW- tasA, which produce 
two matrix proteins. Expression of these components have been shown to be 
vital for stable biofilm formation. Figure taken from Kearns et. al [56]. 
 
Another factor in B. subtilis, EpsE, acts as a molecular clutch that immobilizes the flagellum 
by binding to a flagellar switch protein, FliG. Interestingly, the epsE gene is located in an 
operon that codes for matrix components, suggesting that interruption of motility may 
promote production of biofilm components [33]. Finally, sigma H (σH) is a starvation-
activated transcription factor which is required for B. subtilis developing complex structures 
in biofilms [39].  
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It is known that B. cereus strain may encode a quorum sensing system in which autoinducer-
2 (AI-2) is a regulator [34]. Elevated levels of AI-2 resulted in lower biofilm production as 
well as dispersion of cells from a preformed biofilm.    
 
Also, the pleiotropic regulator PlcR, which influence the expression of at least 45 genes in 
Bacillus cereus [58] by binding to an upstream palindromic motif, have been observed to 
influence biofilm formation in vitro. PlcR is regulated by a small peptide called PapR which 
is itself regulated by PlcR, making it a quorum- like signal system [59]. It has been shown 
that biosurfactants may be essential for biofilm formation in B. cereus, which is directly, or 
indirectly, regulated by PlcR [18]. A B. cereus  ATCC14579 ΔPlcR- mutant produced >4x 
more biofilm compared to wt in a low- nutrient medium (EPS) (p< 0.05) [18].   
 
Finally, the codY gene is recognised to affect biofilm formation by B. cereus, as a codY 
mutant developed four times less biofilm compared to wt in vitro and detached earlier from 
preformed biofilms [60]. The mechanism of action for the codY protein is largely unknown. 
It was shown that codY repressed the production of a 130 kDa protease, but its properties 
have not been thoroughly investigated.  
 
1.3.5 Screening biofilms in the lab 
 
It is difficult to measure biofilm formation in vivo in humans or animal subjects. Most, if not 
all, biofilm research has been done in vitro in the lab. Today, there exist several in vitro 
methods for studying biofilms. None of these are recognized as superior to the others [32]: 
Flow cells are small chambers with transparent surfaces where submerged biofilms may be 
formed and receive nutrition continually.  The biofilms can be easily observed with confocal 
scanning laser microscopy [61]. The strength of this particular approach is the possibility to  
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observe biofilm formation over time. The weakness when using flow cells is that high- 
throughput screening of different strains can be time consuming and difficult  
Floating pellicles that form in the liquid- air- interface in standing cultures may also be used 
for screening of different strains, and it is also an option to grow colonies on agar plates. 
Colonies which exhibit macroscopic, complex architecture are recognised as biofilms and 
may be easily detected by visual inspection [61] . This method may also be used for high- 
throughput screening.  
Finally, microtiter plate based screening techniques can be useful to study submerged or air-
liquid interface biofilms in a no- flow system. Microtiter plate assays are useful for high- 
throughput screening, and a number of genes involved in biofilm formation have been 
discovered by this method [32, 62]. This method was chosen for work in this thesis since it is 
relatively fast to perform on a range of different strains at the same time.  
1.4 Genomics relevant to the thesis 
 
1.4.1 Riboswitches 
 
Riboswitches are typically RNA domains in the 5- untranslated region of certain mRNAs 
adjacent to open reading frames (ORF) that may alter gene expression in response to 
changing concentrations of a specific ligand [63]. The riboswitch domain forms a three- 
dimensional structure with receptor functions which has been shown to bind ligand with high 
affinity and specificity [64]. A whole range of riboswitches have been identified in different 
bacteria, including riboswitches that sense guanine, lysine, adenine, vitamin B12 and other 
ligands. One such domain is GEMM [65] which has been shown to possess high affinity for 
the second messenger c-di-GMP.  
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1.4.2 C- di- GMP 
 
Bis-(3′-5′)-cyclic dimeric guanosine monophosphate (c-di-GMP) is a second messenger 
found in many bacteria [66]. C-di-GMP is produced from two GTP molecules by diguanylate 
cyclases that carry GGDEF domains, and is degraded by phosphodiesterases (PDEs) with 
one of two different domains, EAL or HD- GYP (see figure 5). Most of these enzymes 
contain sensory input domains in the N- terminal transmembrane helices which can sense 
extracellular signals such as oxygen levels and light radiation, and affect enzyme activity. 
 
Intracellular concentrations of c-di-GMP are controlled by the amount and activity of these 
two groups of proteins. The intracellular concentration affects the extent of binding to 
specific effectors, which can be either proteins or riboswitches containing a GEMM domain 
in the 5’- untranslated region. Targets can be promoters in DNA (if the effector is a 
transcription factor), enzymes or complex cellular structures, such as the flagellar basal body 
or exopolysaccharide synthesis [66]. 
 
 
Figure 5: Intracellular c-di-GMP level-based regulation of bacterial cellular 
procecces, two GTP molecules produce c-di-GMP by diguanylate cyclase 
activity (GGDEF domain), and is degraded by phosphodiesterase activity 
(with EAL and HD- GYP domains) to produce pGpG, and later two GMP 
molecules.    
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C-di-GMP is implicated in cell differentiation, conversion between motile and biofilm 
lifestyles (stimulation of biosynthesis of adhesins and exopolysaccharide matrix substances) 
and virulence gene expression in gram-negative bacteria. The role of c-di-GMP in gram-
positive bacteria has, however, not been heavily investigated, and only seven proteins with 
GGDEF and EAL domains have been found [67]. This has led some researchers to be 
doubtful of c-di-GMP as a major regulator of lifestyle behaviour in gram-positive bacteria.  
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Chapter 2: Background for the thesis 
In 2008, Sudarsan et al [63], identified a highly conserved RNA domain, GEMM. GEMM 
resides upstream of genes encoding DGC and PDE proteins in various organisms and 
upstream of genes that are known to sense the intracellular signal molecule cyclic di- GMP 
(1.4.2). The high conservation and genomic distributions of GEMM RNAs are characteristic 
of riboswitches (1.4.1), RNA domains in mRNA that may control translation.  
In their paper, the researchers prepared transcriptional fusions for c-di-GMP riboswitches 
from Bacillus cereus called Bc1 and Bc2 (figure 6), and cloned the constructs into a Bacillus 
subtilis host strain. The expression patterns, using a β-galactosidase assay, revealed that Bc1 
wildtype showed high activity while the isogenic mutant M3 did not. The Bc2 wildtype 
showed low activity while the isogenic mutant M3 showed high activity. These results 
indicated that Bc1 acted as an inducer of downstream gene expression (c-di-GMP- 
responsive “on” switch) whereas Bc2 acted as a repressor of downstream gene expression (c-
di-GMP- responsive “off” switch) [63]. 
 
 
Figure 6: Bc1 and Bc2 RNA sequence and 2D structure. Figure taken from 
Sudarsan et al. support material [63] 
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It has been shown that c-di-GMP is implicated in the change from planktonic to a sedentary 
lifestyle, in biofilm-forming phase in bacteria such as Vibrio cholerae [68]. Putative role of 
c-di-GMP in regulation of biofilm formation in gram-positive bacteria is, however, not 
elucidated. Following the publication of the paper, DNA and protein searches were 
conducted by BLAST [69] to investigate whether these two riboswitches were present in a 
range of different strains in the Bacillus cereus group (Annette Fagerlund, personal 
communication). In one strain, known to be a stable biofilm producer, Bacillus thuringiensis 
407, both riboswitches were present in the genome sequence.   
B. thuringiensis 407 Cry÷ (Bt 407) was chosen as model organism for studying biofilm 
formation due to its well- known ability to produce biofilms and earlier experience in the lab. 
It is a model strain used in many previous studies of B. thuringiensis genetics and has 
recently been sequenced (taxid: 527021). The Bt 407 wildtype was isolated in Brazil by Dr. 
Sergio Batista Alves from an insect larva (Anagasta Kuhniella). It was later cured of plasmid 
encoding insecticidal crystal toxin by heat treatment by Olivia Arantes (Cry
-
). Both wild type 
and mutant strains were first described in 1989 [70]. The parental strain was serotyped at 
Institut Pasteur, and was defined as belonging to serotype H1 (Bacillus thuringiensis serovar 
thuringiensis). However, the serotyping of the 407 Cry÷ strain did not allow distinguishing 
this strain from a B. cereus strain (unpublished data). Plasmid analysis revealed the presence 
of at least six plasmids (ranging from about 4 to 70 kb) in the wildtype strain, Bt 407 Cry+. 
This analysis also showed that strain Bt 407 Cry÷ had lost the largest plasmid of about 70 kb 
(Olivia Arantes and Didier Lereclus, unpublished data).  
The Bc1 riboswitch sequence was identified to be upstream from a gene, bhthur0002_3430 
(locus tag), which will be referred to as Bt407_0422 in this thesis, and which is an ortholog 
of BC0422 in B. cereus ATCC 14579. This open reading frame is annotated to contain 
methyl- accepting chemotaxis protein properties. The Bc2 riboswitch was similarly identified 
at the end of a contig with no adjacent ORF in B. thuringiensis 407. However, an ORF was 
identified by manual inspection, and identified at the end of the contig and continuing on 
another contig. PCR, using genomic DNA from B. thuringiensis 407 as template, and 
subsequent sequence analysis of the PCR product closed the gap between the two contigs, 
revealing the sequence of the gene. The gene was identified to be an ortholog to BC1060 in  
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B. cereus ATCC 14579. BC1060 is annotated to contain collagen- binding adhesion protein 
properties. This gene will be referred to as Bt407_1060 in this thesis.  
In order to control the Bt407_0422 and Bt407_1060 proteins for their effect on biofilm 
formation, Annette Fagerlund prepared gene deletion mutant B. thuringiensis 407 strains of 
both genes and did a preliminary biofilm assay which showed that biofilm formation was 
significantly less in the Bt407_1060 deletion mutant and possibly decreased during the first 
24 hours in the Bt407_0422 deletion mutant compared to the B. thuringiensis 407 wildtype 
strain (unpublished results). The aim of this thesis was to expand on the initial investigation. 
The initial objectives were: 
- Expand biofilm formation screening of the Bt407_1060 and Bt407_0422 gene 
deletion mutants. 
- Clone promotor regions of Bt407_0422 and Bt407_1060 in pHT304-18z (lacZ 
reporter vector) in order to do lacZ assays. 
- Clone the two genes, Bt407_0422 and Bt407_1060, into the pHT304-pXyl expression 
vector for overexpression and complementation assays for the gene deletion mutants.  
 
When the constructs were complete, the aim was to perform different assays and collect data 
relevant to the role of these two genes in biofilm formation. The initial aims would be 
expanded on if time allowed it.  
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Chapter 3: Materials  
3.1 Bacterial strains  
 
Strains Note(s) 
Bacillus  thuringiensis strain 407 (Bt 407)  Further information in chapter 2 
Escherichia coli (E. coli) XL-1 Blue  Manufacturer: Stratagene.  
Escherichia coli (E. coli) electrocompetent cells 
(TOP10) 
Manufacturer: Invitrogen 
Table 3.1: Overview of bacterial strains used in the thesis 
3.2 Vectors (plasmids 
 
Vectors Characteristics Reference 
pHT304-18z pHT304 containing lacZ 
promoterless gene 
Arantes (1991) [71] 
pHT304-pXyl pHT304 containing xylA promoter Arantes (1991) [71] 
pMAD Vector for cloning in gram-positive 
bacteria,  contain β-galactosidase- 
encoding gene and erm 
Arnaud (2004) [72] 
pUC19 Shuttle vector, contains lacZ gene 
and amp 
Yanisch-Perron et al. (1985) [73] 
Table 3.2: Overview of vectors (plasmids) used in the thesis 
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3.3 Oligonucleotides (primers) 
Primer name Sequence (5’-3’) 
02561_F2 aaaggtgggaagccaaaaat 
Bt407_0422-F-XbaI ttatctagattaaggaaggtggatattaatgaaaaa 
Bt407_0422-R-KpnI atcggtaccggagatatcccctttgat 
00330-Bt407_0422-R2 gtcacccacgaacctattca 
S2_pUC19R taacaatttcacacaggaaacagc 
S1_pUC19F gttttcccagtcacgacgtt 
pHT304-pXyl_F2 ggtttgatcagcgatatccac 
pHT304-pXyl_forward tccacttcatccactccatttg 
PU cgccagggttttcccagtcacgac 
OVG cgtaatcttacgtcagtaattccacagta 
P-Bt407_0422-F aacaagcttcgaaattcattagttaagat 
P-Bt407_0422-R ttaggatccaccttccttaattaacataaac 
P-Bt407_1060-F agactgcagcccgagttaagagaaaaag 
P-Bt407_1060-R tacggatcctttgcatagttccctcct 
Bt407_0422_mut1_F ctttgaaaaaatctccaaatcagcgcaatctgttacagatcaag 
Bt407_0422_mut1_R cttgatctgtaacagattgcgctgatttggagattttttcaaag 
Bt407_0422_mut2_F caacagcagtagtaatgttgaagaaagcatgaaagagcaag 
Bt407_0422_mut2_R cttgctctttcatgctttcttcaacattactactgctgttg 
Table 3.3: Overview of oligonucleotides used in the thesis 
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3.4 Enzymes 
 
3.4.1 Restriction enzymes 
 
Restriction enzyme name  Manufacturer 
BamHI   Biolabs 
HindIII Biolabs 
KpnI Biolabs 
PstI Biolabs 
EcoRV Biolabs 
EcoRI Biolabs 
Table 1.4: Overview of restriction enzymes used in the thesis 
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3.4.2 Other enzymes 
 
Enzyme name Manufacturer 
Dynazyme II DNA polymerase Finnzymes 
pfu Ultra polymerase  Stratagene 
T4 DNA ligase Invitrogen 
DpnI Stratagene 
Table 3.5: Overview of enzymes (- restriction enzymes) used in the thesis 
 
3.5 Molecular weight standards 
 
Name Manufacturer 
100bp GeneRuler + DNA ladder (figure 7) Fermentas 
1kb GeneRuler DNA ladder (figure 8)  Fermentas 
Table 3.6: Overview of molecular weight standards used in the thesis 
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3.6 Chemicals 
 
Nr.1 bacterial agar (Oxoid) 
Acetic acid (Merck) 
Acetone (J.T Baker) 
Agarose (Sigma) 
Ampicillin (Sigma) 
Figure 7: GeneRuler 100bp 
Plus DNA ladder 
Figure 8: Generuler 1kb DNA 
ladder 
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Bactopeptone (Oxoid) 
Bromophenol blue (Sigma) 
Boric acid (H3BO3) (Sigma) 
Crystal violet (Sigma) 
Di- Sodium hydrogen phosphate 2- hydrate (Na2HPO4 x 2H2O) (Merck) 
dNTP (Qiagen) 
Erythromycin (Sigma) 
Ethidium bromide (EtBr) (Sigma) 
Ethanol (EtOH) (Arcus) 
Ethylenediaminetetraacetic acid (EDTA) (M&B) 
Hydrochloric acid (HCl) (Prolab) 
Isopropanol (Arcus) 
Kanamycin (Arcus) 
Methanol (Prolab) 
Magnesium chloride (MgCl2) (Merck) 
Magnesium sulphate (MgSO4) (Merck) 
Monopotassium phosphate (KH2PO4) (Merck) 
Potassium chloride (KCl) (Merck) 
Sodium chloride (NaCl) (JT Baker) 
Tetracyclin (Arcus) 
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Tris base (Sigma) 
Tryptone (Oxoid) 
Yeast extract (Oxoid) 
Note: Chemicals provided in the commercial kits are not included in this list. 
3.7 Commercial kits 
 
E.Z.N.A.
®
 Gel Purification Kit (Omega Bio-Tek) 
E.Z.N.A.
®
 Plasmid Miniprep Kit I (Omega Bio-Tek) 
QIAprep Spin Miniprep Kit (50) (Qiagen) 
QIAGEN Plasmid Midi Kit (25) (Qiagen) 
QIAquick PCR Purification Kit (50) (Qiagen) 
QIAquick Gel Extraction Kit (50) (Qiagen) 
3.8 Miscellaneous  
 
0.25µm filter paper (Millipore) 
Eppendorf tubes (2ml) (Treff lab) 
NUNC tubes (15 and 50ml) (Corning) 
8x PCR tubes (0,2ml) with lids (Axygen) 
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Round- bottomed PVC microtiter plates with 96 wells (Falcon 353911) 
Sterilin tubes (15ml) (Sterilin) 
0.2cm electroporation cuvettes (Bio-Rad) 
3.9 Growth media 
Lysogeny Broth medium (LB) 
 
10g tryptone 
5g yeast extract 
10g NaCl 
Dissolved in ~900ml dH20, pH adjusted to 7.0 with HCl and total volume adjusted to 
1000ml with dH20. Autoclaved and stored at 4°C. 
LB agar plates 
 
10g tryptone 
5g yeast extract 
10g NaCl 
15g NR 1 bacterial agar 
Dissolved in ~900ml dH20, pH adjusted to 7.0 with HCl and volume adjusted to 1000ml 
with dH20. Autoclaved and stored at 4°C. 
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Bactopeptone medium 
 
10g bactopeptone 
5g yeast extract 
10g NaCl 
Dissolved in ~900ml dH20, pH adjusted to 7.0 with HCl and volume adjusted to 1000ml 
with dH20. Autoclaved and stored at 4°C. 
 
Super Optimal broth with Catabolite repression (SOC) medium 
 
20g tryptone 
5g yeast extract 
0.5g NaCl 
0.18g KCl 
0.95g MgCl2 
1.2g MgSO4 
3.6g glucose 
Dissolved in 1000ml dH20 and pH adjusted to 7.0 with NaOH. Autoclaved, aliquoted and 
stored at -20°C.  
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3.10 Buffers and solutions  
 
0.3% crystal violet solution (for biofilm assay) 
 
0.6g crystal violet 
Dissolved in 200ml dH20 over night, then sterile filtered and stored at room temperature.  
 
 
6x Loading buffer (for agarose gel electrophoresis) 
 
15ml glycerol 
0,125ml bromophenol blue  
Volume adjusted with ~20ml TBE buffer and dH20 to 50ml total volume. Prepared by 
Annette Fagerlund, aliquoted for own use. 
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Aceton/ethanol (1:4) (for biofilm assay) 
 
250ml acetone 
750ml ethanol 
Mixed and stored at room temperature in sealed container 
 
50x TAE buffer (Tris/Acetate) (for gel electrophoresis) 
 
242 g tris base 
57.1 ml   acetic acid 
100ml 0.5M EDTA (pH 8.0) 
Dissolved in 1000ml dH2O and stored at room temperature.  
PBS (for biofilm assay) 
 
16g NaCl 
0.4g KCl 
0.54g Na2HPO4 x 2H20 
3.56g KH2PO4 
Dissolved in 1900ml dH20, pH adjusted to 7.4 with HCl. Total volume adjusted to 2000ml 
with dH20. Autoclaved, stored at room temperature in a suitable bottle.  
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10x TBE buffer (Tris/Borate) (for gel electrophoresis) 
 
108g tris base 
55g boric acid 
9.3g EDTA 
Dissolved in 950ml dH20. Final volume adjusted to 1L with dH20 in an erlenmeyer bottle. 
Stored at room temperature for further dilution into working concentration (1x).  
50x TAE buffer (Tris/Acetate) (for gel electrophoresis) 
 
242 g tris base 
57.1 ml   acetic acid 
100ml 0.5M EDTA (pH 8.0) 
Dissolved in 1000ml dH2O and stored at room temperature.  
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Chapter 4: Methods 
4.1 Growth of bacteria 
 
4.1.1 Escherichia coli  
 
Escherichia coli (E. coli) was an essential bacterium in the cloning procedure. E. coli was 
grown in either LB medium or on LB agar plates at 37°C, the optimal growth temperature for 
this bacterium. Liquid cultures were subject to rotation at ~220 rpm throughout incubation. 
 
4.1.2 Bacillus cereus 
 
The different strains of Bacillus cereus used in this thesis were grown either in LB or on LB 
agar plates at 30°C, the optimal growth temperature for this bacterium ranges between 28 
and 35°C [17] . Liquid cultures were subject to a rotation of ~220 rpm throughout 
incubation. 
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4.2 Preparation of cells for electrotransformation 
 
4.2.1 Electrocompetent E. coli 
 
Electrocompetent E. coli was made for use in the cloning procedure due to its well- known 
properties regarding transformation of plasmids and fast growth rate.  
Protocol 
 
An appropriate amount of glycerol stock E. coli XL-1 Blue were streaked onto a 20µg/ml 
tetracyclin LB agar plate and incubated at 37°C over night. One colony was picked and used 
to inoculate 50 ml LB medium which was grown at 37°C (220rpm) over night. 10ml of the 
inoculate was transferred to two erlenmeyer bottles, each containing 1000ml LB medium and 
incubated at 37°C (220rpm) until an OD600 value of 0.4- 0.5. Cells were transferred to four 
500ml centrifuge tubes and chilled on ice for 20 minutes. 
The cultures were then centrifuged for 3750x g for 10 minutes at 4°C in a Beckman JA-10 
rotor. The supernatant was then removed by turning the tubes upside down and draining on 
filter paper for a short time. The pellets were then resuspended in 10ml ice-cold MilliQ 
dH2O, and transferred to two centrifuge tubes. After adding 340ml ice-cold MilliQ dH2O, the 
tubes were gently mixed and centrifuged as before. This step was repeated three times.  
After washing, the pellets were resuspended in 10ml ice- cold 7% DMSO. The suspensions 
were then transferred to a 50ml NUNC- tube and the original centrifuge tubes were washed 
thoroughly with another 10ml 7% DMSO and transferred to the NUNC tube (total volume 
40ml). The NUNC tubes with cell suspensions were then centrifuged at 3750x g for 10  
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minutes in a Sorvall RC3C centrifuge. The pellet was resuspended in 4ml 7% DMSO, the 
suspension was dispensed into pre- chilled eppendorf tubes (80µl aliquot) and then frozen on 
a dry ice/ethanol bath prior to transfer and storage at -80°C. The cells were tested for 
transformation effectiveness (5.3). 
4.2.2 Electrocompetent Bacillus cereus 
 
Electrocompetent Bacillus cereus was made in small batches for immediate transformation 
of different reporter vectors for use in the biofilm assay.   
Protocol 
 
The strains to be used for transformation was plated out on LB plates (with appropriate 
antibiotics) and incubated at 30°C overnight. One colony was then transferred to 5ml LB 
medium (with appropriate antibiotics) and incubated at 30°C and ~220rpm overnight.  
The overnight culture was diluted 1:200 in 200ml LB medium in a 1L erlenmeyer bottle and 
incubated at 30°C until an OD600 of 0.4- 0.6. The cultures were harvested by centrifugation 
at 4°C, 4000x g for 10 minutes in a Sorvall RC3C centrifuge. The pellets were washed three 
times with 2ml and once with 1ml 10% glycerol and spun down for 1 minute at 8000rpm 
(4°C) between each wash in a Thermo Heraeus BioFuge table top centrifuge. The cells were 
finally resuspended in an appropriate volume of 10% ice cold glycerol. The cells were used 
for transformation the same day. 
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4.3 Preparation of purified plasmid DNA  
 
Purification of DNA from cell suspensions and liquid reactions was done extensively for this 
thesis. Commercial kits (3.7) from Qiagen and Omega Bio-Tek (E.Z.N.A) were used for this 
purpose, and protocols issued from the manufacturer were followed. The kits are all based on 
the same principle for purification of DNA. If the DNA content was located inside bacteria, 
an alkaline lysis based on the method of Birnboim and Doly [74] was applied. The lysate was 
then neutralized and adjusted to high- salt binding conditions in one or two steps prior to 
application onto a silica membrane for DNA absorption.  
However, if the DNA content was located in a liquid solution (e.g. PCR reactions), the 
volume was adjusted to 100µl and applied directly onto a silica membrane for DNA 
absorption. After 2-3 washes with different buffers to remove RNA, cellular proteins, and 
other metabolites, a low- salt buffer with appropriate pH (usually between 7.0 and 8.5) was 
used to elute the purified DNA from the silica membrane into an eppendorf tube for use in 
other procedures. 
4.3.1 PCR purification 
 
PCR purification was done with EZNA Gel Extraction kit and Qiagen PCR purificiation kit 
(3.7). Protocols provided by the manufacturer were followed [75, 76]. 
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4.3.2 Miniprep 
 
Minipreps of plasmid DNA were prepared with EZNA Miniprep kit and Qiagen miniprep kit 
(3.7). Protocols provided by the manufacturers were followed [77, 78]. 
4.3.3 Midiprep 
 
Midipreps of plasmid DNA was prepared with Qiagen Midiprep kit (3.7). Protocol provided 
by the manufacturer was followed [77]. 
4.4 Determination of DNA concentration in free solutions 
 
Several stages in the cloning procedure depended on knowledge of the DNA concentration in 
liquid solutions. Two different techniques were used for determining DNA concentrations, 
spectrophotometry and/or quantitative electrophoresis. 
 
4.4.1 Spectrophotometry 
 
Absorption spectroscopy of nucleic acids is carried out at 260nm (absorption spectra 
maximum), 1 unit corresponds to ~50µg/ml DNA. To estimate the purity of the solution 
(especially amount of protein contamination), the sample is usually also measured at 280nm  
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(absorption spectra maximum for aromatic amino acids) and a 260/280 ratio is calculated. A 
260/280 ratio of 1.8 indicates 100% DNA and 0% protein [79]. Spectrophotometry was 
carried out using either Eppendorf Bio Photometer or PicoDrop using Picodrop v2.07 
software.  
 
4.4.2 Quantitative electrophoresis 
 
Spectrophotometry was used almost exclusively for samples where the concentration of 
DNA was expected to be high (>500µg/ml). Quantitative electrophoresis was carried out 
when yield of DNA was expected to be uncertain/very low. This was done running several 
dilutions of the test sample on a gel and compare the intensity of the bands with a size 
marker (3.5) where the concentration was known (eg. 5µl 100bp GeneRuler DNA ladder 
(Fermentas)).  
4.5 Polymerase chain reaction (PCR) 
 
Polymerase chain reaction (PCR) is a well- known and common technique to produce large 
quantities of a specific DNA fragment in vitro [80]. PCR requires detailed knowledge of the 
sequence of the DNA segment for precise design of forward and reverse primers. All primers 
used had optimal melting point of ~55°C, and length varied between 15-25 nucleotides, 
except primers used for mutagenesis (see 4.9). 
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Protocol 
 
For practical application, the PCR reaction requires template DNA, forward and reverse 
primers, a heat- stable enzyme with DNA polymerase properties, DNA polymerase buffer, a 
solution containing the four different nucleotides (cytosine, thymine, adenine and guanine) 
and a programmable, automated heat- block.   
 
General setup of PCR reactions (total volume 50µl): 
~50ng chromosomal DNA (usually 1-2µl of solution, either purified plasmid prep or 
resuspended bacterial culture for colony screening) 
1µl DNA polymerase (last component added to the reaction) 
1µl forward primer (20µM) 
1µl reverse primer (20µM) 
5µl 10x DNA polymerase buffer (appropriate for the chosen polymerase) 
dH20 to 50µl 
A general PCR cycle could be like this: 
1. 94°C for 3 minutes, 1 cycle 
2. 94°C for 30 seconds, 50°C for 30 seconds, 72°C for 30 seconds, 30 cycles 
3. 72°C for 3 minutes, 1 cycle, then hold at 4°C until use 
 
It should be noted that the different temperatures and time intervals (especially for the last 
part of the second cycle rotation (where the polymerase copy the template)) could vary, 
depending on the length of the DNA segment to be replicated. PCR in the lab was done 
either on a Thermo PXE 0.2 Thermal Cycler or Applied Biosystems GeneAmp PCR system 
2700.  
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4.6 Gel electrophoresis 
 
Agarose gel electrophoresis was used for separation and purification of specific DNA 
fragments, and was also used for quantitative analysis of DNA concentration in liquid 
solutions (4.4.2). 
DNA fragments of different lengths are separated by several mechanisms [80] p. 16. DNA is 
uniformly, negatively charged, which means that it will travel towards the positive electrode 
in an electric field. However, DNA fragments of different sizes are not separated by their 
size in a free solution with electrodes at either side. A matrix where the DNA has to travel 
through it is important; hence the use of agarose gels. The three- dimensional composition of 
the agarose gel is important, especially the size of the pores. Small, flexible DNA fragments 
are able to migrate faster through a gel compared to longer, less flexible fragments. A gel 
with a high amount of agarosis is usually ideal for separating smaller DNA fragments, and 
vice versa. 
To visualize DNA, ethidium bromide is added to the agarose gels. Ethidium bromide 
intercalates with the DNA, and fluoresces when subjected to UV illumination. 
Protocol 
 
For practical application, the agarose gels used were between 0.5 to 2%, the agarosis was 
added to the buffer used in the electrophoresis chamber in an erlenmeyer bottle (usually 
TBE, but also TAE) and heated until fully dissolved in a microwave oven. Ethidium bromide 
was added to the erlenmeyer bottle in a concentration of 0.5µg/ml and then poured into a gel 
mould for cooling. 
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The gel was then placed into an electrophoresis chamber, a 6x loading buffer (3.10) were 
added to the mixtures of DNA fragments to be separated. A suitable volume of the mixture 
was applied to a separate well in the gel, then ran on 60-120V (adjusted according to the size 
of the gel) for an appropriate time. The DNA fragments were then vizualised with an UV 
illuminator (Biorad Gel Doc 1000) and photographed using Multi- Analyst software. 
To determine size (and to some extent amount of DNA) of the different DNA fragments, 
different size markers were applied on the gels (3.5).  
4.7 Enzymatical restriction digestion 
 
Enzymatical restriction digestion was used both for practical purposes during the cloning 
procedure (cutting and joining of DNA fragments) and for analytical purposes (restriction 
testing). A range of different enzymes were used (3.4.1), but the general setup of each 
reaction was essentially the same.  
Protocol 
 
General setup of restriction digest reaction (total volume 10µl): 
1-2µl template (dependent on concentration of DNA) 
0.5µl restriction enzyme  
1µl 10x reaction buffer (specific to the restriction enzyme) 
If the particular enzyme reaction was dependent on bovine serum albumin (BSA): 
1µl 10x BSA 
dH20 until 10µl  
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It should be noted that the amount of enzyme was changed when necessary, and this general 
setup did not apply for the big digests of plasmid DNA used in parts of the cloning 
procedure.  
4.8 Ligation of DNA fragments 
 
Ligation of two DNA fragments (typically a small insert with a larger reporter vector) was 
done to join digested DNA fragments after DNA purification. The setup of these reactions 
varied with the concentration of insert and vector, but a general rule-of- thumb reaction was 
based on a 1:3 molar ratio between vector and insert. However, it was important to ensure 
that the reaction contained sufficient insert DNA, therefore, the molar ratio could vary 
between 1:3- 1:10. 
Protocol 
 
Ligation reaction (total volume 15µl): 
1µl T4 DNA ligase (last component added to the reaction) 
1.5µl 10x T4 DNA ligase reaction buffer (thawed and vortexed to ensure no precipitation) 
12.5µl vector and insert mixture (depended on the DNA concentrations) 
 
The reactions were then put in a MJ Research Programmable Thermal Controller at 16°C 
overnight. Next day, the reactions were dialyzed for 30 minutes on filter paper to remove 
salts prior to electrotransformation. 
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4.9 Mutagenesis 
 
Mutagenesis can be applied when removal of mutations that could result in erroneous 
translation in a DNA sequence is necessary.  
4.9.1 Primer design 
 
Design was done after guidelines from Quikchange [81] by Annette Fagerlund.  The most 
important features of the primers was length (between 25 and 45bp), estimated melting 
temperature at 78°C, a minimum of 40%GC content and termination in one or more G or C- 
molecules. The mutated base-pair was located in the middle of the primer with >10–15 bases 
of correct sequence on both sides. 
 
4.9.2 Protocol 
 
The protocol from Quikchange [81] was followed. The 
procedure is based on a polymerase chain reaction 
where the primers with the correct sequence are 
designed to overlap the mutation and copy the plasmid. 
After intial PCR reaction, both original, bacterial 
plasmids and newly synthesized plasmids are present.  
Figure 9: Overview of 
mutagenesis using PCR 
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A restriction enzyme, DpnI, that digest target sequence 5´-Gm6ATC-3´ in methylated DNA, 
will then digest the original plasmids while leaving the newly synthesized plasmids intact. 
The reaction is transformed into a proper bacterium, e.g. electrocompetent E. coli and 
sequencing of minipreps from colonies will ratify whether the mutagenesis was successful. 
This procedure can be done several times if more than one mutation is present.  
4.10 DNA sequencing 
 
Sequencing of different constructs was outsourced to the ABI-lab at CEES, Department of 
Biology and Molecular Biosciences, University of Oslo, Oslo, Norway. The lab employs 
3730 high-throughput capillary electrophoresis machines (Applied Biosystems). 
The lab could analyse reactions with 8µl of PCR product with 2µl of a 5µM primer added, 
the general setup was 1-2µl miniprep (>200µg DNA) with 1µl 10mM primer and dH2O to 
10µl for each reaction. 
Analysis of the sequence chromatography diagrams was carried out using Sequence Scanner 
v1.0 (Applied Biosystems). 
4.11 Transformation of circular DNA (plasmids) into 
bacteria 
 
Zimmerman & Vienken (1983) observed that cells can take up exogenous DNA from the 
surrounding environment when treated with high- voltage electric pulses [80]. It has been 
shown that electroporation is as, or more, effective compared to chemical transformation.  
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4.11.1 Transformation into E. coli  
 
Transformation of plasmids into E. coli was done extensively in the cloning procedure. The 
general reaction was 1µl (if TOPO- plasmid) to 15µl (ligation reaction (4.8)) added to ~40µl 
electrocompetent cells.  
The mixture was added to a chilled 0.2cm electroporation cuvette, dried thoroughly and it 
was made sure that no air bubbles were present in the mixture. The cuvette was then placed 
in a Biorad Gene Pulser II machine and electroporated using 2,5kV, 25µF and 400Ω. The RC 
time constant, an estimate of pulse length [82], was expected to be ~10msec. Immediately 
after applying electric shock to the cells, 500µl SOC medium was added and the mixture 
transferred to a 15ml Sterilin tube. Another 500µl SOC medium was added to wash out the 
remaining cells and added to the Sterilin tube. The cells were then incubated at 37°C 
(220rpm) for 1 hour before they were plated out on LB plates with appropriate antibiotics.  
 
4.11.2 Transformation into Bacillus cereus 
 
The electrocompetent cells were prepared the same day as transformation (4.2.2). The 
general reaction setup consisted of 50µl cells and 4µl purified plasmid (~1000-2000µg 
DNA). One or more reactions were prepared (depended on the effectiveness of 
transformation).  
The mixture was added to a chilled 0.2cm electroporation cuvette, dried thoroughly and it 
was made sure that no air bubbles were present in the mixture. The cuvette was then placed 
in a Biorad Gene Pulser II machine and electroporated using 2kV, 25µF and 200Ω. The RC  
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time constant, an estimate of pulse length [82], was expected to be ~4-5msec. Immediately 
after shocking the cells, 500µl SOC medium was added and the mixture transferred to a 
15ml Sterilin tube. Another 500µl SOC medium was added to wash out the remaining cells 
and added to the Sterilin tube. The cells were then incubated on 30°C and ~220rpm for 2-3 
hours before they were plated out on LB plates with appropriate antibiotics.  
4.12 TOPO cloning 
 
Insertion of a PCR product into the TOPO II plasmid 
was done to ease the cloning process due to the 
possibility of indentifying one clone with correct 
sequence and restriction sites.   
TOPO vectors contain replication sites for E. coli 
ampicillin/kanamycin resistance genes and two distinct 
properties for insertion of PCR products. Single 3´-
thymidine (T) overhangs for TA cloning and 
Topoisomerase I covalently bound to the vector (see 
figure 10).  
 
 
The TOPO cloning reaction setup: 
 
 
0.5-4µl fresh PCR product 
1µl TOPO vector 
dH20 until 5µl  
 
 
Figure 10: TOPO 
vector, two 
topoisomerases 
located close to the 
TA overhangs. 
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After mixing, the reaction was left for incubation in room temperature for 5 minutes. The 
entire reaction was then added to electrocompetent E. coli for transformation. 
4.13 Biofilm screening assay 
 
Biofilm formation by Bacillus thuringiensis 407 was studied with a microtiter plate assay 
used in several studies of biofilm formation by Bacillus cereus and other bacteria [34, 62]. In 
order to screen bacterial strains with this assay, the bacteria have to form biofilm at the 
liquid- air interface and it needs to adhere to a plastic surface. Both these properties have to 
be present. The B. thuringiensis 407 strain used in this thesis are known to form biofilms in a 
low nutrition medium (e.g. bactopeptone), and it readily form biofilms which adhere to 
plastic.  
Stock strains were plated onto LB agar plates with appropriate antibiotic(s) and grown at 
30°C over night. One colony were picked and transferred to 5ml LB medium and grown at 
30°C for precisely 18 hours. Then, 50µl were transferred to 5ml LB and grown for 3 hours 
(precultures). The precultures were then diluted 1:200 (usually 50µl in 5ml medium) in 
bactopeptone (with appropriate antibiotics, and for pHT304-pXyl constructs, xylose in 
appropriate concentrations (see results)).  
The bactopeptone cultures were then transferred to 96-well polyvinylchloride (PVC) plates, 
125µl in each well. The plates were put in a moist compartment with a lid, and put inside an 
incubator on 30°C and 50 rpm. Two different incubators were tested, but with no significant 
differences. After growth (24, 48, 72 or 96 hours), the plates were washed and the cultures 
stained with crystal violet in the following manner: 
1) Each well was washed with 130µl PBS  
2) Cells in each well were stained with 130µl crystal violet (0,3%-1%) for 20 minutes 
3) Each well were washed with 180µl PBS  
4) To solubilise the bound, stained cells, 150µl 1:4 acetone/ethanol solution was added 
to each well  
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The absorbance of each well was then measured on 490nm with a HTS 7000 Bio Assay 
Reader (Perkin Elmer). The absorbance for crystal violet is optimal around 590nm, but the 
lab lacked appropriate filters for the assay reader.  
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Chapter 5: Results 
5.1 Bioinformatic analysis of Bt407_0422 and Bt407_1060 
 
As stated in background for the thesis (chapter 2), Bt407_0422 and Bt407_1060 are two 
genes located downstream of the Bc1 and Bc2 riboswitches originally identified by Sudarsan 
and co- workers [63] in Bacillus cereus ATCC 14579 and ATCC 10987, respectively. Initial 
analysis of the gene sequences asserted that the protein products may be important for 
chemotaxis and adhesion, two functions that are known to be important for biofilm 
formation. It was decided to expand the analysis further to ascertain 1) what domains the 
proteins contain, 2) where the domains are located in the protein sequence and 3) identify 
where the protein probably is situated in the bacteria. A limited BLAST search of the protein 
sequences was also done to get an indication on prevalence of resembling proteins in other 
fully, closed sequenced Bacillus strains. A list of the strains included in the BLAST search is 
given below:  
 
 Bacillus  cereus 03BB102 
 Bacillus  cereus AH187 
 Bacillus  cereus AH820 
 Bacillus  cereus ATCC 10987 
 Bacillus  cereus ATCC 14579 
 Bacillus  cereus B4264 
 Bacillus  cereus E33L 
 Bacillus  cereus G9842 
 Bacillus  cereus Q1 
 Bacillus  anthracis Ames 
 Bacillus  anthracis Ames Ancestor 
 Bacillus  anthracis Sterne 
 Bacillus  anthracis str. A0248 
 Bacillus  anthracis str. CDC 684 
 Bacillus  cytotoxicus NVH 391-98 
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 Bacillus  thuringiensis serovar konkukian str. 97-27 
 Bacillus  thuringiensis str. Al Hakam 
 Bacillus  thuringiensis 407 
 Bacillus  weihenstephanensis KBAB4 
 
5.1.1 Sequence analysis of Bt407_1060 
 
A BLAST search of the protein sequence (Appendix 7) of Bt407_1060 was performed to 
investigate the prevalence of Bt407_1060 in the Bacillus cereus group using the 19 closed 
genomes available in Genebank. The search resulted in several hits for various proteins with 
adhesive properties in members of the B. cereus group. Results from the search are 
summarized in table 5.1, showing that only 5 of 19 strains contained a designated ortholog 
(>90% similarity, full query length (2185/2185 amino acids)). 
 
Strain (s) Identity Similarity Query coverage 
Bacillus cereus G9842 2111/2185 (96%) 2138/2185 (97%) 100% 
Bacillus  
weihenstephanensis 
KBAB4 
1936/2168 (89%) 2019/2168 (93%) 99% 
Bacillus cereus ATCC 
14579 
1872/2062 (90%) 1949/2062 (94%) 100% 
Bacillus cereus B4264 1805/2050 (88%) 1913/2050 (93%) 100% 
Bacillus  thuringiensis str. 
Al Hakam 
1613/1773 (90%) 1672/1773 (94%) 100% 
Table 5.1: BLAST search results of the 19 closed genome sequences available 
from the B. cereus group bacteria, Bt407_1060 protein sequence as query 
sequence.   
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Homologous protein sequences found in other strains in the BLAST query contained <30% 
identity and 50% similarity to the original sequence. These results were not included since 
the intent of this search was to identify the extent of closely resembling genes in the Bacillus 
cereus group (orthologs). These paralogous gene sequences may certainly carry similar 
functions, but this is difficult to establish on the basis of this query alone. 
An InterPro scan [1] of the 
Bt407_1060 protein 
sequence revealed several 
key aspects which may be 
important for its function.  
Two domains resembling 
Cna protein B-type domain 
[83] and collagen binding 
domain [84], two domains 
previously identified in 
Staphylococcus aureus to be 
vital parts of the collagen-
binding adhesion protein 
Cna located at the bacterial 
surface. The Cna protein B- 
type domain is necessary to 
elevate the ligand- binding 
domain, collagen binding 
domain, away from the cell 
membrane while the 
collagen binding domain 
contain adhesion properties. 
This domain is part of the bacterial adhesins superfamily.  
Furthermore, the InterPro scan also identified an LPXTG anchor in the C- terminal, which 
indicates that sortase or a related enzyme could potentially cleave between the amino acids  
Figure 11: Putative conserved domains in the protein sequence 
of Bt407_1060 analyzed by InterProScan [1]. 
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threonine and glycine in the region, which is known to result in a covalent anchoring of the 
C- terminal to the cell wall. An N- terminal signal sequence and transmembrane helix 
regions were also identified (figure 11). 
SignalP [2] output revealed a signal peptide cleavage site, which is indicative of proteins 
transported out of the cell by the general secretion machinery, between amino acids 31 and 
32 from the N- terminal (figure 12). A search for twin- arginine peptide cleavage sites 
(TaTP) turned out negative (not shown). 
 
 
 
 
 
Transmembrane helix domains were identified in InterPro near both the N and C- 
terminal of the protein. TMHMM [3] output gave the same result (figure 13). 
 
 
 
Figure 12: SignalP output using the entire Bt407_1060 protein sequence as query [2] 
showing a possible N- terminal signal sequence between amino acids 31 and 32. 
Figure 13: Output from TMHMM analysis of the complete Bt407_1060 protein 
sequence, indicating the presence of two transmembrane regions in the protein [3] 
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On the basis of the accumulated data, it seems probable that 
Bt407_1060 is a protein transported out of the bacteria, anchored to the 
cell wall extracellularly at the C- terminal and carry adhesion 
properties. The InterPro scan identify the sensory domains at the N- 
terminal while a repetitive domain make up the back bone of the 
protein, elevating the sensory areas of the protein away from the cell 
membrane of the bacteria (figure 14). 
 
 
5.1.2 Sequence analysis of Bt407_0422 
 
A BLAST [85] search of the protein sequence (Appendix 7) was performed to investigate the 
prevalence of Bt407_0422 in the B. cereus group, using the 19 closed genomes available in 
Genebank. The search resulted in several hits for various methyl-accepting chemotaxis 
protein(s) in members of the Bacillus cereus group. Results are summarized in table 5.2, 
showing that 4 of 19 strains contained a clear ortholog to Bt407_0422 (99% identity, full 
query length (580/580 amino acids)), and that 15/19 strains contained a protein with >80% 
similarity in sequence.  
Homologous protein sequences were also found in other strains by the BLAST query, which 
contained <30% identity and 50% similarity to the original sequence. These results were not 
included since the focus was on identifying the extent of closely resembling genes in the 
Bacillus cereus group (orthologs). These paralogous gene sequences may certainly carry 
similar functions, but this is difficult to establish on the basis of this query alone. 
 
 
Figure 14: Theoretical location of 
the Bt407_1060 protein. The C- 
terminal is anchored to the cell 
wall and the rest of the protein is 
directed away from the cell. 
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Strain (s) Identity Similarity Query coverage 
Bacillus thuringiensis 
Bt407 
580/580 (100%) 580/580 (100%) 100% 
Bacillus cereus G9842 578/580 (99%) 579/580 (99%) 100% 
Bacillus cereus ATCC 
14579 
576/580 (99%) 579/580 (99%) 100% 
Bacillus cereus B4264 576/580 (99%) 579/580 (99%) 100% 
Bacillus  
weihenstephanensis 
KBAB4 
475/579 (82%) 524/579 (90%) 99% 
Bacillus cereus NVH391-
98 (“cytotoxicus”) 
450/580 (77%) 515/580 (88%) 100% 
Bacillus  thuringiensis 
serovar konkukian Str. 97-
27 
445/579 (76%) 508/579 (87%) 99% 
Bacillus cereus 03BB102 445/579 (76%) 508/579 (87%) 99% 
Bacillus cereus AH820 444/579 (76%) 507/579 (87%) 99% 
Bacillus cereus AH187 445/579 (76%) 504/579 (87%) 99% 
Bacillus cereus Q1 445/579 (76%) 504/579 (87%) 99% 
Bacillus anthracis str. 
Ames  
443/579 (76%) 506/579 (87%) 99% 
Bacillus cereus ATCC 
10987 
443/579 (76%) 503/579 (86%) 99% 
Bacillus  thuringiensis str. 
Al Hakam 
440/580 (75%) 505/580 (87%) 99% 
Bacillus cereus E33L 441/579 (76%) 503/579 (86%) 99% 
Table 5.2: BLAST search results of the 19 closed genome sequences available 
from the B. cereus group bacteria, using the Bt407_0422 protein sequence as 
query sequence. 
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An InterPro [1] search was performed to identify characterized domains in the protein 
sequence, and showed that the Bt407_0422  protein sequence carried domains known to be a 
part of various chemotaxis methyl- accepting proteins (MCP’s)(figure 15). One such domain, 
a methyl- accepting chemotaxis protein (MCP) signalling domain found in Bacillus subtilis, 
has been shown to be homologous to CheW in E. coli, which is important for intracellular 
signalling resulting in flagellar rotation. A B. subtilis cheW mutant displayed impaired 
chemotaxis behaviour [86]. The HAMP linker domain is found in several bacterial sensor 
and chemotaxis proteins [87] and is important for conformational changes in the receptor 
when exposed to ligand [88].  
  
 
Figure 15: Putative conserved domains in the protein sequence of Bt407_0422 
analyzed by InterProScan [1]. 
 
The InterPro scan also revealed a possibility that the Bt407_0422 protein sequence contained 
a SignalP domain, a signal peptide cleavage site which is indicative of proteins transported 
out of the cell by the general secretion machinery. A SignalP [2] search confirmed the most 
likely cleavage site between amino acid 30 and 31 from the N- terminal (figure 16). A search 
for twin-arginine signal peptide cleavage sites common in bacteria [89] did not produce any 
positive hits (not shown). 
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Figure 16: SignalP output using the entire Bt407_0422 protein sequence as 
query [2] showing a possible N- terminal signal sequence between amino acids 
30 and 31. 
 
In order to investigate for transmembrane helixes in Bt407_0422, a TMHMM [3] search of 
the protein sequence was done (figure 17). 
 
 
Figure 17: Output from TMHMM analysis of the complete Bt407_0422 
protein sequence, indicating the presence of two transmembrane regions in 
the protein [3] 
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The TMHMM output indicated two transmembrane regions with a 
large intracellular part. The output does not correlate with the 
general model for methyl- accepting chemotaxis proteins (MCP’s, 
figure 18), where the general notion is that the N- terminal is on the 
cytoplasmic side, followed by a cytosolic region where ligands may 
be anchored and a cytoplasmic region containing the HAMP domain 
and other domains necessary for intracellular signalling [4]. 
However, the TMHMM software is prone to not identify 
intracellular and extracellular regions correctly, and thus the 
knowledge of two membrane- spanning regions is valuable.  
On the basis of the accumulated data, it seems probable that the 
Bt407_0422 protein is a methyl- accepting chemotaxis protein and several orthologs exists in 
various strains belonging to the Bacillus cereus group. The presence of the signalP cleavage 
site indicates that the Bt407_0422 protein is probably transported by the general secretion 
system out of the cell where it is located in the membrane, containing two membrane- 
spanning regions. This correlates well with the domains found in the InterPro scan, the 
designated extracelluar region may contain sensory functions while the intracellular region 
contain HAMP and other signalling domains. 
5.2 Biofilm screening of Bacillus thuringiensis wt and its 
isogenic gene deletion strains ΔBt407_0422 and 
ΔBt407_1060 
 
The first biofilm assay was done to screen for the efficiency of biofilm formation from wt 
and its isogenic gene deletion strains ΔBt407_0422 and ΔBt407_1060 in B. thuringiensis 
407. The two isogenic gene deletion strains were already prepared by Annette Fagerlund  
Figure 18: General model 
for methyl-accepting 
chemotaxis proteins in 
bacteria [4] 
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prior to the thesis, and a small scale microtiter plate assay had been done where it was 
indicated that ΔBt407_1060- mutant produce less biofilm compared to wildtype, and the 
ΔBt407_0422 mutant produce less biofilm during the first 24 hours compared to wildtype, 
but no difference after 48 and 72 hours.  
5.2.1 Microtiter plate assay 
 
In order to screen several Bacillus strains under identical conditions, a microtiter plate assay 
was chosen. The microtiter plate assay is useful for the study of biofilm formed at the air- 
liquid interface, and it is easy to carry out high- throughput screening of several strains at the 
same time. General protocol (4.13) had been established prior to this thesis by collaboration 
with Michel Gohar, INRA, France, and has been used for earlier research on biofilm in 
Bacillus cereus [34, 90]. The protocol was tested and put to practical use in the lab by a 
former master student, Johan Bjørnstad.  
 
Figure 19: Falcon 353011 96- wells PVC microtiter plate used in the 
microtiter plate assay.  
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5.2.2 Biofilm screening of Bt 407 wt, ΔBt407_0422 and ΔBt407_1060 strains 
 
B. thuringiensis 407 wildtype, ΔBt407_0422 and ΔBt407_1060, were grown and prepared 
according to protocol (4.13). The setup of the plates (table 5.3) was designed to get 16 
replicates for each strain on every plate. The design with bactopeptone in between the lanes 
containing a B. thuringiensis 407 strain was done to control whether application of bacteria 
would spread from the designated well to wells adjacent to it, and practical control of the 
researcher. Eight identical plates were prepared in order to get two replicates for every time 
interval, 24h, 48h, 72h and 96h 
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Table 5.3: Design of microtiter plate assay for surface biofilm formation for 
B. thuringiensis 407 and its isogenic gene deletion mutants ΔBt407_0422 and 
Bt407_1060. 
 
 
 71 
 
The first biofilm assay revealed problems with the initial protocol. The HTS 7000 Bio Assay 
Reader used for OD measurements had a cutoff at OD 3. OD measurements of wt and Δ0422 
strains after 48h and 72h exceeded the cutoff of the assay reader and every well had to be 
diluted 1:2.5 (50µl:125µl) in order to get a proper reading. Diluting the wells after 
solubilization with acetone/ethanol was performed quickly in order to avoid extensive 
vaporization.  Following crystal violet staining of the biofilm structures, the degree of 
biofilm formation was measured by optical density measurements (4.13). Results are shown 
in figure 20.  
 
 
Figure 20: Microtiter plate biofilm assay, three different strains, AH1423 
(Bt407 wildtype), AH1539 (ΔBt407_0422) and AH1570 (ΔBt407_1060) were 
grown in 32 wells each on two sets of microtiter plates for 24, 48, 72 and 96 
hours. The wells were washed, stained with 1% crystal violet, solubilized with 
acetone/ethanol and optical density (OD) was measured at 492nm. Vertical 
bars indicate standard deviaton from µ. 
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This experiment showed significantly reduced biofilm formation by the ΔBt407_1060 
mutant compared to wildtype after 24, 48 and 72 hours of incubation which is a strong 
indicator that Bt407_1060 is important for biofilm formation in B. thuringiensis 407. 
However, the experiment did not reveal any significant difference in biofilm formation by 
the ΔBt407_0422 mutant compared to wildtype, which is a difference from the previous, 
smaller study done by Annette Fagerlund where a small difference in biofilm formation 
could be seen after 24 hours. 
5.3 Preparation of electrocompetent cells  
 
In order to study complementation of Bt407_0422 and Bt407_1060 in the isogenic gene 
deletion mutants Bacillus thuringiensis 407 ΔBt407_0422 and ΔBt407_1060, as well as 
overexpression studies in B.thuringiensis 407 wildtype, it was necessary to prepare 
constructs where these two genes were inserted into expression vectors specially made for 
cloning in Bacillus strains, pHT304-pXyl and pHT304-18z. These vectors are constructed to 
express ampicillin resistance in both E. coli and Bacillus cereus, enabling the researcher to 
do the preliminary cloning work done in E. coli prior to transformation into B. cereus. This is 
an advantage since cloning and commercial kits are readily available for E. coli, whereas 
cloning work in B. cereus are more complicated (further information concerning these 
vectors, see 5.4.3 and 5.6.3). In order to perform electrotransformation of plasmid DNA in 
the cloning procedure, it was necessary to prepare electrocompetent cells of E. coli.  
Electrocompetent E. coli, using the strain Escherichia coli (E. coli) XL-1 Blue, were made 
following lab protocol (4.2.1). After washing and storage at -80°C, ~40-50µl cells from the 
new batch, as well as commercially prepared cells (TOP10, 3.1), were transformed with 10pg 
of three different plasmids, pUC19, pMAD and pHT304-18z (3.1.2), 1000µl SOC medium 
was added and the cells were incubated at 37°C for one hour. 1µl, 10µl and 100µl cell-
medium suspension were plated out in duplicate LB plates with 100µg/ml ampicillin, and 
incubated at 37°C overnight. The cells were then counted using a colony counter (Gerber  
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Instruments), and colony forming units (CFU)/µg transformed DNA was estimated for the 
different plasmids. In order to estimate CFU/µg DNA, the mean of the three different plates 
(duplicate) were calculated and corrected for dilution. E.g. if 1 colony appeared on the LB 
plate after applying 1µl medium (1000µl=10pg): 
 = =  
CFU/µg for each plate was then estimated, and an overall mean calculated for each plasmid: 
 
pUC19 CFU electrocompetent cells 
1µl medium 18,5 
10µl medium 372,5 
100µl medium 2543 
Mean CFU/µg DNA 2,706x10
9
CFU/µg 
Table 5.4: Estimation of CFU/µg DNA after transformation of 10pg pUC19 
plasmid into E. coli and corrected for dilution (see above for calculation).  
 
pMAD CFU electrocompetent cells 
1µl medium 5 
10µl medium 47 
100µl medium 540 
Mean CFU/µg DNA 5,033x10
8
CFU/µg 
Table 5.5: Estimation of CFU/µg DNA after transformation of 10pg pMAD 
plasmid into E. coli and corrected for dilution (see above for calculation). 
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pHT304-18z CFU electrocompetent cells 
1µl medium 2 
10µl medium 34 
100µl medium 512 
Mean CFU/µg DNA 4,26x10
8
CFU/µg 
Table 5.6: Estimation of CFU/µg DNA after transformation of 10pg pHT304-
18z plasmid into E. coli and corrected for dilution (see above for calculation). 
 
 
pHT304-pXyl CFU electrocompetent cells 
1µl medium 12 
10µl medium 103 
100µl medium 972 
Mean CFU/µg DNA 9,985x10
8
CFU/µg 
Table 5.7: Estimation of CFU/µg DNA after transformation of 10pg pHT304-
pXyl plasmid into E. coli and corrected for dilution (see above for 
calculation). 
 
The estimated CFU/µg for this batch was satisfactory, and the cells were expected to work 
well during the following cloning procedures. The results indicated that the transformation 
efficiency of the different plasmids varied, pUC19 (table 5.4) was the most efficient plasmid, 
and vastly more efficient compared to the vector pMAD (table 5.5).  
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5.4 Cloning of Bt407_0422 into pHT304-pXyl reporter 
vector 
 
In order to study complementation of Bt407_0422 in Bacillus thuringiensis 407 
ΔBt407_0422 and overexpression of Bt407_0422 in B. thuringiensis 407 wt, it was decided 
that the gene Bt407_0422 first would be cloned in a TOPO II vector and transferred, after 
proper verification of correct sequence, into the expression vector pHT304-pXyl. The 
Bt407_0422 – pHT304-pXyl construct would then be transferred to the various strains of B. 
thuringiensis 407 for the functional studies concerning biofilm formation.  
The pHT304-pXyl vector is a shuttle vector constructed for cloning in B. thuringiensis and 
E. coli; it contains two antibiotic resistance markers, an ampicillin resistance gene functional 
in E. coli and an erythromycin resistance gene functional in both E. coli and B. thuringiensis 
[71]. Additionally, this particular vector contain the xylA promotor from Bacillus subtilis, 
which is induced by increasing xylose concentrations, reaching a plateau at 16,7mM [91]. 
5.4.1 PCR  
 
Initial PCR (4.5) amplification of the Bt407_0422 gene was performed with 
primers Bt407_0422-F-XbaI-/Bt407_0422-R-KpnI (3.3), which would initiate 
replication upstream and downstream of the gene Bt407_0422 in the B. 
thuringiensis 407 genome. A genome prep made from B. thuringiensis 407 
was used as template. The length of the PCR product was expected to be 
~1816bp. 10µl of the PCR product was applied to a gel (4.6) for 
control, along with a negative control lacking template DNA. The PCR 
product was of the expected size (figure 21).   
Figure 21: Lanes: 1: 1kb 
st. (Fermentas), 2: PCR 
product Bt407_0422 . 
Lane 3:  Negative control 
without genome as 
template, no bands (not 
shown) 
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5.4.2 TOPO cloning 
 
For the next step, it was desirable to clone the Bt407_0422 PCR product into a TOPO vector 
to be able to do qualitative control of the Bt407_0422 fragment prior to transfer into the 
shuttle vector pHT304-pXyl. The PCR product was inserted into a TOPO II vector following 
standard protocol (4.12). The Bt407_0422 – pHT304-pXyl construct was then transformed 
into electrocompetent E. coli XL-1 blue MRF- cells (4.11.1) and incubated on LB plates 
containing 100 µg /ml ampicillin / 50 µg/ml kanamycin / 80µg/ml x-gal. Ten white colonies 
were picked and controlled using colony PCR (4.5) with primers S2_pUC19R/00330-
Bt407_0422-R2 (3.3) and controlled by agarose electrophoresis for size and specificity (4.6). 
The expected size of the PCR product was ~673bp.  
 
 
Figure 22: Colony PCR of the Bt407_0422 – TOPO construct. Lanes: 1: 100bp st. 
(Fermentas), lanes 2-11: PCR products from colony 1-10 picked from LB plates. 
 
Electrophoresis showed that nearly all colonies seemed to contain the desired PCR product -
TOPO plasmid (figure 22), but it was speculated that some of the wells were overflowed 
after application of reactions on the gel. Two colonies were prepared for miniprep and 
restriction testing, while four other were prepared for glycerol stocks.  
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5.4.3 Restriction testing 
 
Plasmid minipreps were prepared (4.3.2) from the two colonies from lane 3 and 7, and were 
tested by restriction digestion using enzymes EcoRV and KpnI (4.7). The colony from lane 7 
had expected sizes after analysis by agarose electrophoresis (4.6)(figure 23 and 24) whereas 
the  colony from lane 3 lacked the KpnI restriction site. 
 
 
 
 
 
 
 
 
 
 
It was decided to proceed with a large digest and subcloning the Bt407_0422 insert from the 
colony from lane 7 into the pHT304-pXyl expression vector.  
 
Figure 23: In silico restriction 
test, expected band size with 
EcoRV, KpnI and XbaI 
restriction enzymes 
Figure 24: Restriction test of 2 colonies 
containing Bt407_0422- TOPO. Lanes: 1: 
1kb st. (Fermentas), 2: Colony 1 cut with 
EcoRV, 3: Colony 2 cut with EcoRV, 4: 
Colony 1 cut with KpnI, 5: Colony 2 cut 
with KpnI, 6-7: Colony 1 and 2 without 
restriction enzymes. 
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5.4.4 Subcloning of Bt407_0422 in pHT304-pXyl vector 
 
In order to express Bt407_0422 in B. thuringiensis 407, we wished to move the cloned 
Bt407_0422 fragment from the Bt407_0422 – TOPO vector to pHT304-pXyl. Bt407_0422-
TOPO and pHT304-pXyl were both double digested with XbaI and KpnI and separated on a 
preparative agarose gel (4.6). The XbaI/KpnI double digest had produced DNA bands of the 
expected sizes (figure 25). 
 
 
Figure 25: Large restriction digest. Lanes: 1: Bt407_0422 –TOPO double digested 
with XbaI and KpnI, 2: Uncut pHT304-pXyl vector, 3: 1kb st. (Fermentas), 4: 
pHT304-pXyl double digested with XbaI and KpnI. The Bt407_0422 band can be seen 
on the left (~2000bp) and was excised. It was separated from the TOPO vector and 
uncut vector (~4000-6000bp).  On the right, the pHT304-pXyl vector is separated from 
uncut vector (top band on the right) and was excised. 
 
As can be seen in figure 25, the Bt407_0422 fragment (~2000bp) was separated from the 
TOPO vector and uncut vector, and was excised carefully from the gel. The digested 
pHT304-pXyl vector (clearly visible band with ~8000bp) was separated from uncut vector 
(top band) and was also excised from the gel. Both DNA fragments were purified by using a 
commercial PCR purification kit (4.3.1) and concentrations of DNA was measured using 
both spectrophotometry (4.4.1) and quantitative gel electrophoresis (4.4.2).  
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The next step was to ligate the digested Bt407_0422 insert with the digested pHT304-pXyl 
vector. Two reactions were set up, one reaction with 1:3 molar ratio of vector/insert and one 
reaction with 1:5 molar ratio, and ligated overnight at 16°C (4.8). Ligation reactions were 
then dialyzed on filter paper for 30 minutes, transformed into electrocompetent E. coli 
(4.11.1) and plated out on LB plates containing 100µg/ml ampicillin / 200µg/ml 
erythromycin. No colonies were detected after 24 hours of growth at 37°C. A second 
identical cloning experiment did not produce any colonies.  
It was discovered that the Bt407_0422-TOPO construct did not contain the restriction site for 
XbaI when the Bt407_0422 – TOPO vector was tested with XbaI and KpnI separately. The 
reason why this was not discovered earlier was that the BC0422- TOPO vector contains two 
restriction sites for both XbaI and KpnI (figure 26) which are located close to each other. 
When XbaI was not present, the fragment produced by digest with KpnI would still be 
approximately the same length and, therefore, not possible to discover with a double digest.  
 
Figure 26: Bt407_0422 – TOPO vector with restriction sites marked. The 
Bt407_0422 insert is located from the XbaI site (340) to the KpnI site (2148). 
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Unfortunately, the original restriction test did not include XbaI, only KpnI and EcoRV. 
Restriction tests with XbaI and KpnI on minipreps from the four untested, positive colonies 
(5.3.3) turned out to be negative. It was decided to start the cloning procedure with a new 
PCR amplification of the Bt407_0422 gene in B. thuringiensis 407. 
Cloning of Bt407_0422 PCR product and insertion into TOPO vector was done as previously 
described (5.4.1-5.4.3). Minipreps from four colonies supposed to contain Bt407_0422 – 
TOPO was prepared (4.3.2) and restriction tested with XbaI, KpnI and EcoRI (figure 27). 
Two of the colonies turned out to have both restriction sites intact, and the DNA fragments 
had the correct size. It was decided to proceed with colony 4. 
 
 
Figure 27: Restriction test of four colonies supposed to contain Bt407_0422 – TOPO. 
Lanes: 1: 100bp st. (Fermentas), 2-4: Colony 1 cut with XbaI, KpnI and EcoRI, 5-7: 
Colony 2 with XbaI, KpnI and EcoRI, 8: 100bp st. (Fermentas), 9-11: Colony 3 cut 
with XbaI, KpnI and EcoRI, 12-14: Colony 4 cut with XbaI, KpnI and EcoRI, 15: 100bp 
st. (Fermentas) 
 
Two new attempts at ligating the Bt407_0422 fragment with the pHT304-pXyl vector did not 
give any colonies (not shown). Visual inspection of the LB plates after ligating the 
fragments, transformation into E. coli and 24 hours of growth at 37°C showed a viscous layer 
of cell debris. It was attempted to streak samples of this layer onto fresh LB plates containing 
100µg/ml ampicillin / 200µg/ml erythromycin, but no colonies were detected. It was then 
discovered by comparing protocols in the lab that the erythromycin concentration for growth  
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of E. coli containing pHT304-pXyl constructs preferably should’ve been 400µg/ml, not 
200µg/ml.  
A fourth attempt resulted in several colonies (>100) on the plates after 24 hours of growth. 
Colony PCR with primers pHT304-pXyl_forward/00330-Bt407_0422-R2, which would 
amplify a part of the pHT304-pXyl vector and a part of the Bt407_0422 fragment (expected 
size 780bp), turned out negative for 19 colonies. A positive control with an empty vector 
turned out to be positive (figure 28). 
 
 
Figure 28: Colony PCR of colonies supposed to contain Bt407_0422 – pHT304-pXyl. 
Lanes: 1: 100bp st. (Fermentas), 2-18: Colony 1-18, 19: Positive control with empty 
vector (pHT304-pXyl), 20: 100bp st. (Fermentas) 
 
In order to understand what plasmid was present in the colonies that appeared on the plates, 
several tests were done. A miniprep was prepared for one colony (4.3.2) and tested with XbaI 
and KpnI, but no DNA bands were detected after gel electrophoresis (4.6, not shown). 
A colony PCR with three different primer sets (pHT304-pXyl_forward/S2_pUC19R, 
S1_pUC19F/S2_pUC19R and Bt407_0422-XbaI-forward/00330-Bt407_0422-R2) turned out 
negative (not shown).  
However, an identical cloning procedure done by Annette Fagerlund gave several colonies. It 
was discovered that colonies would develop both after 24 and 48 hours of growth, all 
colonies tested previously was picked after 24 hours. In this cloning experiment, colonies 
were counted after 24 hours and 48 hours, and 40 colonies that appeared after 48 hours were 
tested by colony PCR with primers pHT304-pXyl_forward/00330-Bt407_0422-R2.  
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The colony PCR, done by Annette Fagerlund, showed that 
>20 colonies contained the Bt407_0422- pHT304- pXyl 
construct (not shown). It was decided to proceed with four 
colonies. Minipreps were made (4.3.2), and each plasmid prep 
was restriction tested with XbaI-KpnI (double digest), EcoRV, 
SacI and a non-digested miniprep to be able to separate 
digested and non- digested DNA (figure 29 and 30). All four 
colonies had the expected number and sizes of bands.  
 
 
 
 
 
 
 
 
Figure 30: Restriction test of four colonies supposed to contain Bt407_0422 – pHT304-
pXyl. Lanes: 1: 1kb st. (Fermentas), 2-5: Colony 1 cut with KpnI-XbaI, EcoRV, SacI 
and uncut, 6-9: Colony 2 with KpnI-XbaI, EcoRV, SacI and uncut, 10-13: Colony 3 cut 
with KpnI-XbaI, EcoRV, SacI and uncut, 14-17: Colony 4 cut with KpnI-XbaI, EcoRV, 
SacI and uncut, 18: 1kb st. (Fermentas). 
 
 
 
 
 
Figure 29: In silico restriction test, 
expected band sizes after digest 
with 3 enzymes in Bt407_0422-
pHT304-pXyl construct 
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5.4.5 Sequence analysis  
 
It was decided to proceed with colony 1. Plasmid DNA was prepared for sequencing (4.10) 
with primers pHT304-pXyl_forward, S2_pUC10R, 00330-Bt407_0422-F2 and 00330-
Bt407_0422_R2. The first and second primers are located upstream and downstream of the 
Bt407_0422 insert while the third and fourth primers are located inside the Bt407_0422 
fragment, with opposite directions. Analysis (Appendix 4) revealed two mutations in the 
Bt407_0422 sequence compared to the published sequence in Genebank. Since the cloning 
procedure up to this point had been difficult, it was decided to apply in vitro mutagenesis 
(4.9) to correct the mutations.  
5.4.6 First mutagenesis 
 
For the first mutation, a miniprep (4.3.2) of Bt407_0422-pHT304-pXyl was prepared. Primer 
set Bt407_0422_mut1_F/Bt407_0422_mut1_R (3.3) was used in the first mutagenesis. 
Following the Quikchange II protocol (4.9.2), 4µl of the sample and control (reaction 
identical to sample except that no primers are added) reaction , respectively, were 
transformed into electrocompetent E. coli XL-1 blue MRF cells (4.11.1) and plated on LB 
plates containing 100µg/ml ampicillin / 400µg/ml erythromycin. After incubation for 24 
hours at 37°C, sample and control plates were counted. There were ~5x more colonies on the 
sample plates compared to control. This is a control of whether the restriction enzyme DpnI 
successfully digested the plasmids replicated in E. coli while leaving the newly synthesized 
plasmids from the PCR intact. Six colonies were picked and minipreps prepared (4.3.2). 
Samples from the six minipreps were sent for DNA sequencing with S2_pUC19R as primer. 
This primer is located downstream of the Bt407_0422 gene in the Bt407_0422 – pHT304-
pXyl vector. Analysis (Appendix 5) showed that the mutation had been corrected for colony 
3, 4 and 6.  
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5.4.7 Second mutagenesis 
 
For the second mutation, a miniprep of Bt407_0422- pHT304-pXyl from colony 3 from the 
first mutagenesis (5.4.6) was prepared. Primer set 
Bt407_0422_mut2_F/Bt407_0422_mut2_R (3.3) was used in the second mutagenesis. 
Following the Quikchange II protocol (4.9.2), 4µl of the sample and control reaction 
(reaction identical to sample except that no primers are added) were transformed into 
electrocompetent E. coli XL-1 blue MRF cells (4.11.1) and plated out on LB plates with 
100µg/ml ampicillin/400µg/ml erythromycin. After incubation for 24 hours at 37°C, sample 
and control plates were counted. The amount of colonies on the sample and control plates 
was ~equal. This is a control of whether the restriction enzyme DpnI successfully digested 
the plasmids replicated in E. coli while leaving the newly synthesized plasmids from the 
PCR intact. In this case, the procedure had seemingly not been able to eradicate the original, 
mutated vector.  Minipreps from four colonies were prepared and sent to sequence with 
S2_pUC19R as primer. This primer is located downstream of the Bt407_0422 gene in the 
Bt407_0422 – pHT304-pXyl vector. Analysis (Appendix 6) of the four sequences showed 
that colony 2 and 4 no longer contained any of the two original mutations (5.4.5). Colony 2 
from this procedure was chosen for further work. Bt407_0422-pHT304-pXyl from this 
colony was transformed into electrocompetent E. coli XL-1 Blue MRF (4.11.1), and glycerol 
stocks were prepared and stored at -80°C (registered as AH1661 in the AH registry). 
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5.5 Complementation of Bacillus thuringiensis 407 
ΔBt407_0422 and ΔBt407_1060 gene deletion mutants 
 
Biofilm assays done with Bacillus thuringiensis 407 ΔBt407_0422 and ΔBt407_1060 
isogenic gene deletion mutants and wild type strains had previously shown that the deletion 
of Bt407_1060 seemingly resulted in impaired biofilm formation (5.2).  
In order to determine the role of Bt407_0422 and Bt407_1060 in biofilm formation in B. 
thungiensis further, constructs of Bt407_0422-pHT304-pXyl and Bt407_1060-pHT304-pXyl 
were transformed into wildtype (wt) and gene deletion mutant strains of Bt 407 for over-
expression and complementation studies on biofilm formation over time using the microtiter 
plate assay (4.13). 
 
5.5.1 B. thuringiensis 407 (Bt 407) variant strains 
 
In order to do complementary/over-expression studies, 10 variants of the B. thuringiensis 
407 (Bt 407) strain were needed.  
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Name  AH register Vector carried Gene deletion Use 
Bt 407  AH1423 None  None  Wt 
Bt 407 + pXyl AH1684  pHT304-pXyl None Control 
Bt 407 + Bt407_0422 AH1685 Bt407_0422-
pHT304-pXyl 
None  Bt407_0422  
overexpression 
Bt 407 + Bt407_1060  AH1686 Bt407_1060-
pHT304-pXyl 
None Bt407_1060  
overexpression 
Bt 407Δ0422  AH1539 None  Bt407_0422  ΔBt407_0422 
Bt 407Δ0422 + pXyl AH1688 pHT304-pXyl  Bt407_0422 Control 
Bt 407Δ0422 + 0422 AH1687 Bt407_0422-
pHT304-pXyl 
 Bt407_0422 Complementation 
Bt 407Δ1060 AH1570 None   Bt407_1060 Δ1060 
Bt 407Δ1060 + pXyl AH1690 pHT304-pXyl Bt407_1060 Control 
Bt 407Δ1060 + 1060 AH1689 Bt407_1060-
pHT304-pXyl 
 Bt407_1060 Complementation 
Table 5.8: Schematic overview over Bt 407 variant strains for use in the 
biofilm screening to determine the effect of Bt407_0422 and Bt407_1060 on 
biofilm formation. 
 
5.5.2 Electrotransformation of insert- reporter vectors into Bt407 
 
The two gene deletion mutants of Bt 407 had been prepared by Annette Fagerlund prior to 
the thesis. Stock strains AH1660 (Bt407_1060 - pHT304-pXyl in E. coli XL-1 blue MRF, 
construct cloned by Annette Fagerlund) and AH1661 (Bt407_0422-pHT304 - pXyl in E. coli  
 
 87 
 
XL-1 blue MRF) were grown (4.1.1) and minipreps of both plasmids prepared prior to 
transformation (4.3.2). 
Bt 407 wildtype, Bt 407Δ0422 and Bt 407Δ1060 were prepared for electrotransformation 
(4.2.2). ~50µl cells were mixed with vector, transformed (4.11.2) and plated on LB plates 
with 10µg/ml erythromycin. The plates were grown over night at 30°C. Two to three 
colonies were picked and streaked onto new LB plates containing 10µg/ml erythromycin and 
grown for another 24 hours at 30°C. One to ten colonies were then inoculated in 50µl LB 
medium, 5µl of the inoculate was used to inoculate 5ml LB to prepare glycerol stocks, while 
45µl was heated at 94°C for 15 minutes and 1µl was then used as template for colony PCR. 
Primers were chosen to give PCR products <1000bp.  
Cells transformed with pHT304-pXyl were screened using primer set pHT304-
pXyl_forward/ S2_pUC19R. The expected size of the PCR product was 327bp.  
Cells transformed with Bt407_0422 - pHT304-pXyl were screened using primer set pHT304-
pXyl_forward/ 00330-Bt407_0422-R2. The expected size of the PCR product was 800bp.  
Cells transformed with Bt407_1060-pHT304-pXyl were screened using primer set 
S2_pUC19R/02561_F2. The expected size of the PCR product was 800bp.  
Altogether, the five transformations (designated AH1684, AH1686, AH1688, AH1689 and 
AH1690) were performed in the first round of experiments, and all five were transformed 
successfully (figure 31). 
 
 
 
 
 
 
 88 
 
 
Figure 31: Colony PCR of colonies of B. thuringiensis 407 strains with pHT304-pXyl 
and Bt407_1060-pHT304-pXyl. Lanes: 1: 100bp st. (Fermentas), 2-3: AH1423 
(wildtype) +pHT304-pXyl, 4-5: AH1423 (wildtype) +Bt407_1060-pHT304-pXyl, 6-7: 
AH1539 (Bt 407Δ0422) + pHT304-pXyl, 8-9: AH1570 (Bt 407Δ1060) + Bt407_1060-
pHT304-pXyl, 10-11: AH1570 (Δ1060) + pHT304-pXyl, 12: 100bp st. (Fermentas). 
 
The two remaining Bt 407 variant strains, Bt 407 wildtype + Bt407_0422 - pHT304-pXyl 
and Bt 407 Δ0422 + Bt407_0422 - pHT304-pXyl, were subsequently successfully 
transformed afterwards (designated AH1685 and AH1687), similar to the first Bt 407 variant 
strains (figure 32). Three glycerol stocks were prepared of each of the seven clones, and 
stored at -80°C.  
 
 
Figure 32: Colony PCR of colonies of B. thuringiensis 407 strains with Bt407_0422 – 
pHT304-pXyl. Lanes: 1: 100bp st. (Fermentas), 2-4: AH1423 (Bt 407 wildtype) + 
Bt407_0422 - pHT304-pXyl, 5-7: AH1539 (Bt 407Δ0422) + Bt407_0422 - pHT304-
pXyl. 
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5.5.3 Optimization of xylose concentration for overexpression and 
complementation studies 
 
To be able to do overexpression and complementation studies with Bt 407- based strains 
containing the Bt407_4022 and Bt407_1060 - pHT304-pXyl, it was necessary to do a xylose 
titration study to ascertain the xylose concentration needed for appropriate expression levels.   
The experimental setup of the microtiter plate screening assay is shown in table 5.9. We 
started out doing a complementation study of Bt 407Δ1060 with Bt407_1060 - pHT304-pXyl 
(AH1689) set up according to the protocol (4.13). To be certain that the pHT304-pXyl vector 
itself did not change biofilm formation, Bt 407Δ1060 with pHT304-pXyl (AH1686) was 
included for control. Four identical microtiter plates were set up, and biofilm formation was 
measured after 24, 48, 72 and 96 hours, respectively (4.13). 
However, the biofilm formation at the air-liquid interface for this assay was highly unstable. 
Visual inspection of the plates, after initial wash and staining with crystal violet, showed that 
large fragments of biofilm ring had been lost during plate handling. The results from OD 
measurements of the Bt 407 wt, Bt 407Δ0422 and Bt 407 Δ1060 strains did not comply with 
results generated in previous assays in the lab (5.2). The unstable biofilms were observed in 
every well, both the strains where xylose was added and the strains without xylose.  
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Table 5.9: Microtiter plate design for complementation assay for deletion of 
Bt407_1060 with Bt 407 wildtype, Bt 407Δ0422 and Bt 407Δ1060 strains. AH1689: 
Bt407Δ1060 with Bt407_1060-pHT304-pXyl, AH1690: Bt407Δ1060 with pHT304-
pXyl. Wells containing bacteria carrying plasmids were added 10µg/ml erythromycin. 
 
A repeated biofilm assay designed in the same manner as the first xylose titration assay 
(5.5.3, table 5.9) showed the same problems with biofilm stability, as did a similar 
complementation titration assay with the Bt407Δ0422 strains containing the Bt407_0422- 
pHT304 - pXyl plasmid.  
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5.5.4 Control of biofilm assay method  
 
To control whether another external unknown factor was affecting biofilm formation, a 
microtiter plate assay was set up in the same manner as the previous biofilm screening assay 
with Bt 407 wildtype (AH1423) and Bt 407Δ0422 (AH1539)/ Bt 407Δ1060 (AH1570) gene 
deletion mutant strains. Visual inspection and OD measurements showed no problem with 
biofilm stability after 24 hours of growth at 30°C (figure 33). This small study did not show 
the significant difference between Bt 407 wt and Bt 407Δ1060 on biofilm formation as was 
observed in the biofilm screening assay described in 5.2, but the aim here was to ascertain 
whether the biofilm formation was disrupted in the same manner as the xylose titration 
assays or not. No such disruption was observed. 
 
 
Figure 33: Control of biofilm screening assay results using Bt 407 wt (AH1423), Bt 
407Δ0422 (AH1539) and Bt 407Δ1060 (AH1570). The bacteria were applied to a 
microtiter plate (8 wells each) for 24 hours of growth at 30°C, washed, stained and OD 
measured as stated in the protocol (4.13). 
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Since no problems were present in the biofilm assay described above, it was speculated that 
xylose or erythromycin could have a destabilizing effect on biofilm formation since only the 
biofilm assays where these two chemical components were present exhibited unstable 
biofilm formation. A second theory was that the design of the plates itself, with wells 
containing bacteria adjacent to each other could result in biofilm instability. The stable 
biofilm screening assays had wells containing bactopeptone medium to separate the wells 
containing bacteria. The third theory was that the bactopeptone medium used was not 
prepared correctly. A 24h and 48h control of these three theories did not resolve the biofilm 
instability issue (not shown). 
 
5.6 Cloning of promoter regions for Bt407_0422 and 
Bt407_1060 into pHT304-18z reporter vector to create 
lacZ fusion constructs 
 
In order to study the regulation of Bt407_0422 and Bt407_1060 in Bacillus thuringiensis 
407, it was decided that the promoter regions identified upstream of these two genes that was 
similar to the Bc1 and Bc2 riboswitches described by Sudarsan [63] should be cloned in a 
TOPO II vector and transferred, after proper verification of correct sequence, to the reporter 
vector pHT304-18z in order to do lacZ studies.  
pHT304-18z is a shuttle vector constructed for cloning in B. thuringiensis and E. coli. It 
contains two antibiotic resistance markers, an ampicillin resistance gene functional in E. coli 
and an erythromycin resistance gene functional in both E. coli and B. thuringiensis. It also 
contains a promotorless lacZ gene which codes for a β-galactosidase enzyme [71]. 
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5.6.1 PCR  
 
Promoter regions, hereby designated as promBt407_0422 for the promoter region upstream 
from Bt407_0422 and promBt407_1060 for the promoter region upstream from Bt407_1060, 
were amplified by PCR (4.5) with primers P-Bt407_0422-F/P-Bt407_0422-R for 
promBt407_0422 and P-Bt407_1060-F/P-Bt407_0422-R for promBt407_1060 (3.1.3), using 
genome DNA from B. thuringiensis 407 as template. The estimated lengths of the PCR 
products were expected to be 498bp and 404bp, respectively. 
10µl of the PCR products were applied on an agarose gel for electrophoresis, along with a 
negative PCR control lacking template DNA (figure 34) for each primer set. 
 
 
Figure 34: Initial PCR of promBt407_0422 and promBt407_1060. Lanes: 1: 100bp st. 
(Fermentas), 2: PCR product of promBt407_0422, 3: Negative control of PCR of 
promBt407_0422 without genome as template, 4: PCR product of promBt407_1060, 5: 
Negative control of PCR of promBt407_1060 without genome as template. 
 
5.6.2 TOPO cloning 
 
The PCR products covering the promoter regions (5.6.1) were then inserted into a TOPO II 
vector (4.12), hereby designated promBt407_0422 – TOPO and promBt407_1060 – TOPO,  
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respectively, and the constructs were transformed into electrocompetent E. coli XL-1 blue 
MRF- cells (4.11.1) and plated on LB plates containing 100µg/ml ampicillin / 50µg/ml 
kanamycin. Several colonies were picked and screened by colony PCR (4.5) with primers 
S2_pUC19R/P-Bt407_0422-R for promBt407_0422 and S2_pUC19R/P-Bt407_1060-R for 
promBt407_1060 (3.1.3). The PCR products were checked on agarose gels for size and 
specificity. The expected sizes of the PCR products were 643bp and 549bp, respectively. The 
colony PCR revealed one positive colony for each promoter region (figure 35 and 36). 
 
 
Figure 35: Colony PCR of colonies supposed to contain promBt407_0422 – TOPO. 
Lanes: 1: 100bp st. (Fermentas), 2-11:  Colony 1-10.  
asd 
 
Figure 36: Colony PCR of colonies supposed to contain promBt407_1060 – TOPO. 
Lanes: 1: 100bp st. (Fermentas), 2-11:  Colony 1-10. 
 
5.6.3 Restriction test 
 
In order to verify whether the promoter regions had been inserted correctly into the TOPO 
vector, restriction digest tests were done using enzymes known to be present in the  
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promBt407_0422 – TOPO and promBt407_1060 plasmids. Plasmid minipreps of each 
promoter- TOPO construct were prepared (4.3.2).  
 
 
A restriction test (4.7) with a 1:10 dilution of the minipreps, using BamHI and EcoRI for 
each promoter, gave bands with correct sizes for promBt407_1060 - TOPO, but not for 
promBt407_0422 – TOPO (figure 37,38 and 39). 
 
 
 
 
 
 
Figure 37: In silico 
restriction digest test of the 
promBt407_1060 – TOPO 
plasmid. 
Figure 38: In silico 
restriction test of the 
promBt407_0422 – TOPO 
plasmid. 
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An additional restriction test using plasmid DNA from two additional colonies supposed to 
contain promBt407_0422 – TOPO, using the enzymes BamHI and EcoRI, respectively, 
resulted in the identification of one positive clone (figure 40). 
 
 
Figure 40: Restriction test of minipreps made from 2 colonies supposed to contain 
promBt407_0422 – TOPO. Lanes: 1: 1kb st. (Fermentas), 2: Colony 1 cut with 
BamHI, 3: Colony 2 cut with BamHI, 4: Colony 1 cut with EcoRI, 5: Colony 2 cut with 
EcoRI, 5: Uncut miniprep from colony 1, 6: Uncut miniprep from colony 2. 
 
 
Figure 39: Restriction test of minipreps from 2 colonies supposed to contain 
promBt407_0422 – TOPO and promBt407_1060 – TOPO. Lanes. 1: 1kb st. 
(Fermentas), 2: promBt407_0422 cut with BamHI, 3: promBt407_1060 cut with 
BamHI, 4: promBt407_0422 cut with EcoRI, 5: promBt407_1060 cut with EcoRI. Both 
photos show the same gel, but more light is applied to the photo on the right to 
illuminate the 438bp band produced when promBt407_1060 - TOPO is digested with 
BamHI. 
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An additional restriction test with PstI and SspI for the previously identified, positive 
colonies for each promoter gave a positive result (not shown). It was decided to continue to 
transfer the promoter to the reporter vector, pHT304-18z.  
 
5.6.4 Large digest, cutting, purification and ligation of insert and reporter 
plasmids 
 
The aim of the next step was to digest promBt407_0422 - TOPO and pHT304-18z with 
BamHI and HindIII, purify and finally ligate the DNA fragments together. Similarly, 
promBt407_1060-TOPO and pHT304-18z would be digested with BamHI and PstI and be 
purified and ligated (table 5.10). 
 
promBt407_0422-TOPO pHT304-18z  promBt407_1060-TOPO 
Digest with BamHI 
DNA purification 
promBt407_0422-TOPO 
digested with BamHI 
pHT304-18z digested with 
BamHI  
promBt407_0422-TOPO 
digested with BamHI 
Digest with HindIII Digest with PstI 
Tabell 5.10: Schematic overview of transfer of inserts to reporter vector 
 
Both inserts (~25µg) and reporter vector (~2µg) was digested with BamHI. All reactions 
were purified using a commercial DNA purification kit (3.7). The reporter vector sample was 
digested with BamHI and equally split into two different reactions; one reaction was digested 
with HindIII and one reaction with PstI (table 5.10). The double digested vector samples 
were then separated on a 0.7% SeaKem GTG preparative agarose gel (4.6)(figure 41).  
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Figure 41: Large restriction digests. Lanes: 1: pHT304-18z digested with BamHI and 
HindIII, 2: uncut vector, 3: 1kb st. (Fermentas), 4: pHT304-18z digested with BamHI 
and PstI 
 
BamHI- digested promBt407_0422 - TOPO and promBt407_1060 - TOPO were then 
digested with HindIII and PstI, respectively, and separated on a 1.2% NuSieve GTG 
preparative agarose gel (4.6)(figure 42). 
 
  
Figure 42: Large digest of promBt407_0422 – TOPO and promBt407_1060 – TOPO. 
Lanes: 1: promBt407_0422 –TOPO digested with BamHI and HindIII, 2: 100bp st. 
(Fermentas), 3: promBt407_1060 – TOPO digested with BamHI and PstI. 
 
DNA bands were excised from the gels and purified with a commercial DNA purification kit 
(4.3.1). After purification of DNA from the gel, the different DNA fragments were quantified 
by spectrophotometry or quantitative gel electrophoresis (4.4.1 and 4.4.2), Two ligation 
reactions were set up, one with 1:3 molar ratio of vector/insert and one with 1:5 molar ratio 
of vector/insert. The reactions were then ligated at 16°C overnight (4.8). The ligation  
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reactions were then dialyzed on filter paper for 30 minutes the next day, transformed into E. 
coli (4.11.1) and plated on LB plates containing 100µg/ml ampicillin / 200µg/ml 
erythromycin / 80µg/ml X-gal. After incubation at 37°C overnight, no colonies were 
detected.  
An additional restriction test revealed that promBt407_0422-TOPO and promBt407_1060-
TOPO had both restriction digest sites intact (not shown). However, sequence analysis 
revealed a single mutation in the promoter region of promBt407_1060-TOPO (appendix 1 
and 2). An additional analysis of the original PCR template turned out to contain no 
mutations (appendix 5). It was decided to start the cloning procedure for promBt407_1060 
from the beginning, following the same protocol. A miniprep of promBt407_1060 - TOPO 
was generated from a new colony, and restriction tested with BamHI, PstI and SspI (not 
shown). It was decided to again attempt to transfer the promoter regions to the pHT304-pXyl 
reporter vector.  
Two addition attempts turned out negative, visual inspection of the LB plates showed a 
viscous layer of cell debris on the plates. The third attempt included several ligation controls 
where the vector pHT304-18z was digested with BamHI and ligated together, as well as 
double digested promBt407_0422 – TOPO and promBt407_1060 was transformed without 
ligase added to the ligation reaction. The controls suggested that nothing was wrong with the 
procedure. It was then discovered by comparing protocols in the lab that the erythromycin 
concentration for growth of E. coli containing pHT304-18z constructs preferably should’ve 
been 400µg/ml, not 200µg/ml. 
For the last attempt, the amount of erythromycin was changed from 200 to 400µg/ml 
erythromycin. Transformed cells plated on LB plates containing 100µg/ml ampicillin / 
400µg/ml erythromycin / 80µg/ml X- gal gave several colonies (>100) for both 
promBt407_0422 - pHT304-18z and promBt407_1060 - pHT304- 18z constructs.  
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5.6.5 Colony PCR screening of pHT304-18z constructs 
 
Twenty colonies of each construct were picked and screened by colony PCR using primers 
PU and OVG (3.1.3). The PU primer is located upstream from the insert site in pHT304-18z 
while OVG is located downstream. The expected size of the PCR products was between 500-
1000bp. Electrophoresis (figure 43 and 44) indicated that none of the colonies contained the 
expected constructs. 
 
 
Figure 43: Colony PCR of colonies supposed to contain promBt407_0422 - pHT304-
18z. Lanes: 1: 100bp st. (Fermentas), 2-21: Colony 1-20, 22: 100bp st. (Fermentas). 
 
 
Figure 44: Colony PCR of colonies supposed to contain promBt407_1060 - pHT304-
18z. Lanes: 1: 100bp st. (Fermentas), 2-19: Colony 1-18, 20-21: Positive control with 
midiprep of empty vector (pHT304-18z), 22: 100 bp st. (Fermentas). 
 
The colonies were screened by two additional primer sets each; both sets contained one 
primer upstream and one primer downstream of the insert site in pHT304-18z, but none of 
the PCR’s produced the expected bands, indicating that the clones did not carry the expecting  
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plasmids. Plasmid minipreps were prepared (4.3.2) followed by restriction testing using 
BamHI, HindIII and PstI, but no bands were detected after gel electrophoresis (4.6). 
Due to lack of time, no further work was done on the promBt407_0422 and 
promBt407_1060 inserts.  
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Chapter 6: Discussion  
6.1 Role of Bt407_0422 and Bt407_1060 in biofilm 
formation by B. thuringiensis 407 
 
Preliminary results by Annette Fagerlund indicated that gene deletion of Bt407_1060 in B. 
thuringiensis 407 resulted in lower biofilm formation after 24, 48 and 72 hours of growth 
compared to wt. Gene deletion of Bt407_0422 seemed to result in a slightly lower biofilm 
formation after 24 hours compared to wt, but not after 48 and 72 hours.  
 
6.1.1 The role of Bt407_1060 in biofilm formation by B. thuringiensis 407 
 
The more extensive screening performed for this thesis (5.2.2) confirmed that gene deletion 
of Bt407_1060 in B. thuringiensis 407 results in significantly lower biofilm formation after 
24, 48 and 72 hours using a microtiter plate screening assay in vitro (4.13). However, the 
mutant was able to produce biofilm to a certain extent. Bt407_1060 should, therefore, be 
considered an important/highly influental gene in biofilm formation by B. thuringiensis 407, 
but not essential.  
BLAST search of the protein sequence (5.1.1) revealed that orthologs of Bt407_1060 are not 
heavily distributed throughout the nineteen strains with closed genomes included in the 
search, and the presence of these orthologs did not absolutely correlate with strong biofilm 
producer capabilities (table 6.1). A biofilm producing strain such as B. cereus ATCC 10987 
did not contain any Bt407_1060 ortholog, which means that Bt407_1060 is not a 
determining factor of biofilm formation in this strain. 
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Strains Biofilm Bt407_1060 ortholog 
Bacillus cereus ATCC 10987 Positive (+) [19, 90] Not present 
Bacillus cereus ATCC 14579 Negative (-) [90] Present 
Bacillus cereus AH187 Negative (-) [90] Not present 
Bacillus cereus NVH391-98 Negative (-) [90] Not present 
Bacillus thuringiensis 407 Positive (+) [90]  Present 
Bacillus anthracis Sterne Positive (+) [92] Not present 
 
Table 6.1: Overview of a selection of B. cereus group strains where data on 1) 
biofilm formation and 2) the presence of Bt407_1060 orthologs is available. 
 
In order to explain the results from the functional studies, information regarding the putative 
properties of Bt407_1060 and knowledge of key factors in biofilm formation by B. 
thuringiensis 407 is important. Bt407_1060 and its orthologs in other sequenced strains 
were, initially, annotated as a collagen- binding protein. Analysis of the Bt407_1060 protein 
sequence (5.1.1) showed that it contains two domains which closely resemble the collagen- 
binding domain and Cna-like B-type domain characterized in Staphylococcus aureus [83], 
constituting the ligand binding domain and the domain responsible for elevation of the 
binding domain away from the cell wall, respectively. Furthermore, an LPXTG- motif was 
identified near the C- terminal which meant that it may be anchored extracellularly to the cell 
wall. Supporting this theory, a SignalP cleavage site was also discovered which meant that 
the protein may be transported by the general bacterial secretion apparatus (Sec). Based on 
these results, it seems probable that the initial annotation is correct and the Bt407_1060 
protein may be involved in adhesion/cell- to- cell interactions, however, whether is the real 
ligand remains to be functionally established.  
The importance of adhesion for establishing a monolayer attached to a surface and cell- to- 
cell interactions in development of multilayer biofilms is well known [32]. Not much  
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research has been done on protein- mediated adhesion by B. cereus and B. subtilis, biofilm 
research in Bacillus species have focused almost exclusively on components of the biofilm 
matrix and their regulators. However, it has been shown that B. subtilis SpoOA gene deletion 
mutants were not able to develop biofilm beyond a monolayer [93], and it was suggested that 
this effect was due to impaired cell-cell interaction. EPS and TasA, two components 
regulated by SpoOA and is secreted out of the bacterium , have been shown to be important 
since mutant strains are not able to produce a stable biofilm [40].   
In other gram- positive bacteria, such as S. epidermidis and S. aureus, initiation of biofilm 
formation has been linked to cell-surface interactions [94]. Several studies have implicated a 
polysaccharide intercellular adhesin (PIA) to be important for cell- cell- interactions and 
formation of cell aggregates on a surface [94, 95]. Deletion of the ica locus coding for this 
adhesin resulted in impaired biofilm formation compared to wildtype in one study [96]. 
Addiotionally, the protein Bap (biofilm associated protein) is a surface protein with adhesin 
properties that has been observed to affect biofilm formation on a polystyrene surface by S. 
aureus [62].  
To conclude, results from screening assays indicate that Bt407_1060 may have a functional 
role in biofilm formation since a B. thuringiensis 407 ΔBt407_1060 mutant exhibited 
impaired biofilm formation. The theoretical adhesion properties of the Bt407_1060 protein, 
as well as the potential role of c-di-GMP in regulation of the expression of Bt407_1060, are 
intriguing since research concerning adhesion in biofilm formation by Bacillus species is 
scarce. However, complementation studies are necessary to rule out any possible polar 
effects from unexpected, additional mutations arising from the gene deletion procedure. 
 
6.1.2 The role of Bt407_0422 in biofilm formation by B. thuringiensis 407  
 
The more extensive screening in this thesis (5.2.2) showed no difference in biofilm 
formation between Bt 407 wt and the ΔBt407_0422 gene deletion mutant.  
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This is in conflict with previous preliminary assays where a small difference was observed 
during the first 24 hours of growth. Thus, it seems probable that Bt407_0422 is not an 
essential gene in biofilm formation by B. thuringiensis 407. However, the results do not rule 
out that an effect may be observed when applying other screening techniques.  
Annotation in sequenced B. cereus group genomes indicated that the Bt407_0422 protein 
was a methyl-accepting chemotaxis protein (MCP). Analysis of the Bt407_0422 protein 
sequence (5.1.2) revealed a HAMP domain and other intracellular domains usually found in 
chemotaxis proteins. Furthermore, a signal cleavage site and two transmembrane regions 
were identified, indicating that the protein is transported by the general secretion apparatus 
(Sec) out of the cell and constitute a transmembrane protein, respectively. The positioning of 
these domains indicated that Bt407_0422 contains an extracellular helix with sensory 
functions and an intracellular region with signalling properties. This correlates well with the 
general model for methyl- accepting chemotaxis proteins [4] and the initial annotation is 
considered correct. 
Chemotaxis is responsible for sensing chemical gradients in close proximity to the cell and, 
through intracellular signaling for motility towards favorable conditions by affecting the 
flagellar apparatus [97]. Bacteria usually contain several different receptors; 10 different 
chemotaxis receptors have been identified in B. subtilis which are able to sense a wide range 
of different ligands [97]. Methyl-accepting chemotaxis proteins undergo a conformational 
change after binding of ligand, and, through several signalling steps, result in 
phosphorylation of the effector protein CheY which determines the direction of flagellar 
rotation [4].  
 
A role of chemotaxis in biofilm formation has not been described. One possibility could be 
that chemotaxis is required for the bacteria to swim towards nutrients associated with a 
surface. Chemotaxis is linked to, and influences motility by regulation of flagellar 
movement, but one study done in E. coli showed that motility and flagellar movement 
mutants produced a severely impaired biofilm while chemotaxis mutants produced biofilms 
similar to wt [98].  
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Transcriptional studies have indicated that genes encoding methyl- accepting chemotaxis 
proteins are highly activated during monolayer formation [31]. This suggests that chemotaxis 
may have a role either in further development into a multilayer biofilm or in dispersion of the 
biofilm, two actions which require motility.  
 
B. thuringiensis 407 is motile, contains an extensive flagellar apparatus and shows 
swimming/swarming behaviour in vitro [99]. B. subtilis cells with a dysfunctional flagellar 
apparatus exhibit lower biofilm forming capabilities compared to wt [100]. In that study, 
chemotaxis is shown not to be a determining factor for biofilm formation. Thus, the results in 
B. subtilis correlate well with the results experienced with the ΔBt407_0422 mutant strain. 
The design of the microtiter plate screening assay for this thesis, however, is arguably not the 
ideal model to investigate whether the theoretical chemotaxis protein Bt407_0422 has an 
effect on biofilm formation. Since one of the key factors for initiation of biofilm formation 
by motile bacteria is the ability to move towards a surface or the air-liquid interface, the 
rotation during incubation could theoretically bring most cells in close proximity by 
rotational force.  
To conclude, Bt407_0422 is a gene which is most likely coding for a methyl- accepting 
chemotaxis protein. However, functional studies did not show any effect on biofilm 
formation. This was not entirely unexpected since several studies on biofilm formation have 
concluded that chemotaxis was not essential for biofilm formation. Since it is possible to 
observe differences in biofilm formation behaviour in different screening systems [32], it 
would be interesting to perform additional studies in other systems where chemotaxis may be 
more favourably modelled. 
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6.1.3 The role of c-di-GMP on Bt407_1060 and Bt407_0422 in biofilm 
regulation  
 
In gram-negative bacteria, the general effect of c-di-GMP on biofilm formation is that 
elevated c-di-GMP levels in the cell increase adhesion, while suppressing motility [66], 
causing a shift from  a motile lifestyle to a biofilm-forming lifestyle. However, this 
seemingly doesn’t apply to the control of Bt407_0422 and Bt407_1060, where the opposite 
effect was seemingly found. Elevated c-di-GMP was found, by Sudarsan and co-workers, to 
increase Bc1 (c-di-GMP- responsive “on” switch) activity [63] which will increase 
Bt407_0422 expression and, therefore, potentially increase chemotaxis. Elevated c-di-GMP 
was found to decrease Bc2 (c-di-GMP- responsive “off” switch) activity [63] which will 
suppress Bt407_1060 expression and, therefore, potentially reduce adhesion [63]. Lower c-
di-GMP will produce the opposite effects. C-di-GMP levels and regulatory processes in 
different environments in Bacillus species are, however, poorly investigated. It has been 
claimed that extracellular c-di-GMP added to the growth medium inhibits biofilm formation 
by Staphylococcus aureus [101]. This study is, however, more concerned about the action of 
c-di-GMP on cell-to- cell interaction and biofilm formation as a possible drug candidate, and 
the intracellular signalling during biofilm formation has not been properly investigated. In 
the paper, the researchers pondered whether the observed effect was due to extracellular 
rather than the more biologically relevant intracellular actions of c-di-GMP [101].  
In order to enhance our understanding of Bt407_0422 and Bt407_1060, further studies on c-
di-GMP level variations in Bacillus species would be of great interest and is one of the future 
aspects of this project (6.4). 
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6.2 Cloning procedure of Bt407_1060 and Bt407_0422 
promoter regions in pHT304-18z vectors 
 
The original aim, to produce constructs of the promoter regions of Bt407_0422 and 
Bt407_1060 with the pHT304-18z reporter vector, was not met. There are several reasons for 
this. The first, and most important reason, is the complexity of the cloning procedure itself 
which meant that initial negative results was more likely to be a result of imprecise 
laboratory technique. Although most procedures in the beginning included negative and/or 
positive controls if it was deemed prudent, troubleshooting was not always done after initial 
negative attempts.  
The initial TOPO cloning procedure did not present any problems. The qualitative control of 
promoter-TOPO constructs, however, turned out to be insufficient. The procedure was based 
on restriction testing with a selection of enzymes, including the restriction sites incorporated 
in the primers for the initial PCR. Restriction testing is a fast and cheap technique that may 
reveal if the bulk of the DNA is correct, and if the expected restriction sites are present. 
However, point mutations in the sequence might be left undiscovered if DNA sequencing is 
not applied, as it did with the sequence for the promoter region for Bt407_1060. When 
obtained, it was discovered that two point mutations were present and the entire cloning 
procedure up to that point had to be redone.  
The cloning procedures could then progress to the transfer of promoter regions from the 
TOPO vector to the pHT304-18z vector. Several attempts were made following the original 
protocol but no colonies were detected. This procedure was done twice prior to 
troubleshooting. Control of the ligation procedure with positive controls (single- cut vector 
which was ligated and produced colonies) and negative controls (double- cut vectors without 
insert and which produced no colonies) suggested no systematic problems with the 
procedure. Comparison of other lab protocols revealed that 400µg/ml erythromycin, not 
200µg/ml as was stated in the original protocol, was prudent. A layer of cell debris had been  
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observed on the LB plates during previous attempts, the same phenomenon was observed 
with LB plates older than a month containing 400µg/ml erythromycin. One suggestion is that 
the previous attempts possibly were successful in joining the promoter regions with the 
reporter vector, but the lack of antibiotics might have resulted in low natural selection 
pressure which meant that bacteria not containing the plasmids were not eradicated as 
thorough as they should have been. However, the cloning attempts with 400µg/ml 
erythromycin turned out to only give contaminants, and extensive testing with colony PCR, 
using primers designed to detect the other vectors employed regularly in the lab, and 
restriction digests gave no answers to what these colonies contained. In other studies, such as 
the initial construction of the shuttle vector pHT304 [71], 150µg/ml erythromycin was used.  
 
Due to time issues, focus was shifted from the cloning procedure to get the Bt407_0422 and 
Bt407_1060 pHT304-pXyl constructs ready for biofilm assay.  
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6.3 Complementation/overexpression of Bt407_0422 and 
Bt407_1060 proteins in Bacillus thuringiensis 407    (Bt 
407) 
 
In order to control whether the effect observed by the ΔBt407_1060 and ΔBt407_0422 gene 
deletion mutants was due to some other, external factor present, both genes were inserted 
into pHT304-pXyl expression vectors in order to do complementation studies in the mutant 
strains and overexpression in the Bt 407 wildtype strain. The cloning procedure was 
successful, but the necessary titration of xylose with the constructs was not.  
6.3.1. Cloning of Bt407_0422 into pHT304-pXyl shuttle vector 
 
The cloning of Bt407_0422 into pHT304-pXyl was riddled with similar problems as the 
promoter regions (6.2), however, there were some additional issues which had to be solved. 
At least two attempts of transferring the Bt407_0422 fragment to TOPO to pHT304-pXyl 
were performed before it was discovered that the restriction site for XbaI was missing from 
the TOPO construct. The reason for this may have been either an error in the primer itself, or 
a point mutation that developed later in the procedure. The cloning procedure up to this point 
had to be redone.  
Although the attempts to transfer the Bt407_0422 insert into pHT304-pXyl were riddled with 
difficulties, one cloning attempt done by Annette Fagerlund was successful. Sequence 
analysis of these clones revealed two point mutations in the sequence. The most probable  
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reason for this was the use of Dynazyme II polymerase for the initial PCR reaction 
(Finnzymes, [102], an enzyme with less proofreading properties compared to e.g. Pfu 
(Promega, [103]) which contains 3’-5’ exonuclease activity. In the end, the mutations were 
dealt with using mutagenesis; the construct was finished and transformed into E. coli and B. 
thuringiensis 407. 
6.3.2 Xylose titration of Bt407_0422 and Bt407_1060- pHT304- pXyl 
constructs 
 
Xylose titration experiments, where the goal was to ascertain optimal concentrations of 
xylose in the bactopeptone medium for expression of Bt407_0422 and Bt407_1060 from the 
pHT304-pXyl shuttle vector, for complementation and overexpression studies, respectively, 
did not work. The reason for this is enigmatic. The biofilm assay performed satisfactory 
when comparing the ΔBt407_1060 and ΔBt407_0422 gene deletion mutant strains to wt, but 
even these strains, with no xylose or antibiotics added to the wells, produced unstable 
biofilms when xylose or antibiotics were added to other strains in other wells on the same 
microtiter plate. This particular effect was observed no less than three times, followed by a 
control screening with Bt 407 wt and the gene deletion mutants Bt 407 ΔBt407_1060 and 
ΔBt407_0422, where no xylose or antibiotics was added to the plate, which reproduced the 
formation of stable biofilms seen in the first screening assay experiment (5.2.2). 
It was speculated whether xylose, or the presence of antibiotics for selection of bacteria 
containing plasmids, could have an inhibitory effect on biofilm formation. However, it is 
known that most Bacillus species utilize glucose, not xylose, as a carbon source [17]. 
Glucose is known to inhibit biofilm formation in Bacillus subtilis [53] , but this mechanism 
does not seem to be affected by xylose, and there are no other data concerning this available. 
Additional experiments are absolutely required to resolve whether the effect of xylose, or 
antibiotics for plasmid selection, is truly inhibitory of biofilm formation for B. thuringiensis. 
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6.4 Future aspects 
 
In the end, some of the aims of the thesis were met and some were not. There are several 
interesting possibilities to expand on the work done in this thesis. The first priority would be 
to ascertain the correct xylose concentration for the Bt407_0422 and Bt407_1060 – pHT304-
pXyl vectors and proceed with the complementation and overexpression studies. Due to the 
collected results from the functional studies, complementation of Bt407_1060 would be of 
great interest in order to ratify the results from the functional studies (5.2.2).  
The next priority for future work on the biofilm project would be to finish the transfer of the 
promoter regions from the TOPO constructs to the pHT304-18z reporter vector. The finished 
constructs could be used in lacZ studies to 1) investigate time of activation during growth or 
2) transform the constructs into c-di-GMP synthesis gene deletion mutants and identify what 
genes in Bacillus thuringiensis 407 regulate the riboswitches controlling Bt407_1060 and 
Bt407_0422 expression. 
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Appendixes 
Appendix 1: Sequence analysis of promBt407_0422-
TOPO (9-11-2009) 
 
Original sequence; pCR II-TOPO-promoter of Bt407_0422 in Bt 407, forward 
direction: 
aacaagcttcgaaattcattagttaagatatattcgaatagtttaatttgaatgaaaattaaataaatacccgaagaaatccttgttgtttatac
attttttattatataacacaaaaaaagtaacattcacgtactttttgaaattattttgaaaaagcaatgcattaaaaatttgtatttatatctctaaa
taagtagacattttgatttatatgttgtaatctttgaaagagaataaattaattctcatagaactcccatatcgttcaactcgttCAGCGA
GAAAGGCAAACTGATGGAAACATGAGGACGCAAAACTACAGGAGCTAAGGTCG
AAAGGCTACGCTAGCCAGTTACCGGACGgatagggttggtcttggccaatgcttttacattggcttttttttattc
tcgaacatattgagaaacattttcaaacaaaatattcatatattttgtttttttgtttatgttaattaaggaaggtggatcctaa 
Obtained sequence, pCR II-TOPO-promoter of Bt407_0422 in Bt 407, 
S2_pUC19R: 
aagcttcgaaattcattagttaagatatattcgaatagtttaatttgaatgaaaattaaataaatacccgaagaaatccttgttgtttatacattt
tttattatataacacaaaaaaagtaacattcacgtactttttgaaattattttgaaaaagcaatgcattaaaaatttgtatttatatctctaaataa
gtagacattttgatttatatgttgtaatctttgaaagagaataaattaattctcatagaactcccatatcgttcaactcgttcagcgagaaagg
caaactgatggaaacatgaggacgcaaaactacaggagctaaggtcgaaaggctacgctagccagttaccggacggatagggttgg
tcttggccaatgcttttacattggcttttttttattctcgaacatattgagaaacattttcaaacaaaatattcatatattttgtttttttgtttatgtta
attaaggaaggtggatccaa 
Emboss analysis (http://emboss.bioinformatics.nl/emboss/output/201692/, 9/11-2009) 
revealed no mutations. 
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Original sequence; pCR II-TOPO-promoter of Bt407_0422 in Bt 407, 
complementary, reverse strand: 
ggatccaccttccttaattaacataaacaaaaaaacaaaatatatgaatattttgtttgaaaatgtttctcaatatgttcgagaataaaaaaaa
gccaatgtaaaagcattggccaagaccaaccctatccgtccggtaactggctagcgtagcctttcgaccttagctcctgtagttttgcgtc
ctcatgtttccatcagtttgcctttctcgctgaacgagttgaacgatatgggagttctatgagaattaatttattctctttcaaagattacaacat
ataaatcaaaatgtctacttatttagagatataaatacaaatttttaatgcattgctttttcaaaataatttcaaaaagtacgtgaatgttacttttt
ttgtgttatataataaaaaatgtataaacaacaaggatttcttcgggtatttatttaattttcattcaaattaaactattcgaatatatcttaactaa
tgaatttcgaagcttg 
Obtained sequence, pCR II-TOPO-promoter of Bt407_0422 in Bt 407, 
S1_pUC19F: 
ggatccaccttccttaattaacataaacaaaaaaacaaaatatatgaatattttgtttgaaaatgtttctcaatatgttcgagaataaaaaaaa
gccaatgtaaaagcattggccaagaccaaccctatccgtccggtaactggctagcgtagcctttcgaccttagctcctgtagttttgcgtc
ctcatgtttccatcagtttgcctttctcgctgaacgagttgaacgatatgggagttctatgagaattaatttattctctttcaaagattacaacat
ataaatcaaaatgtctacttatttagagatataaatacaaatttttaatgcattgctttttcaaaataatttcaaaaagtacgtgaatgttacttttt
ttgtgttatataataaaaaatgtataaacaacaaggatttcttcgggtatttatttaattttcattcaaattaaactattcgaatatatcttaactaa
tgaatttcgaagcttg 
Emboss analysis (http://www.ebi.ac.uk/Tools/es/cgi-bin/jobresults.cgi/needle/needle-
20091109-1341299280.html, 9/11-2009) revealed no mutations. 
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Appendix 2: Sequence analysis of promBt407_1060-
TOPO (9-11-2009 
 
Original sequence; pCR II-TOPO-promoter of Bt407_1060 in Bt 407, forward 
direction: 
ctgcagcccgagttaagagaaaaagtgattcaagctcttattggtaattcatataaatagaatatacgaactatataatgcgaaaataattc
accattgcttctttaatgcagtcgtgaattattttttttattagaaaaatagaacaattttatagagtattgaattataaccgtccagacggtata
gtaatatttggtttaagaggaaaatgaaacaaaaaaaagaataaaagatatttttagcacactattcgaaaggataggccgcaaagctta
gagtctacggtaatacatattggttactaagatcgtctggttgcacatttttgatgcaaccggacggtctttttttgttatataaatataaaaaa
taggagggaactatgcaaaggatcc 
Obtained sequence, pCR II-TOPO-promoter of Bt407_1060 in Bt 407, 
S2_pUC19R: 
ctgcagcccgagttaagagaaaaagtgattcaagctcttattggtaattcatataaatagaatatacgaactatataatgcgaaaataattc
accattgcttctttaatgcagtcgtgaattattttttttattagaaaaatagaacaattttatagagtattgaattataaccgtccagacggtata
gtaatatttggtttaagaggaaaatgaaacaaaaaaaagaataaaagatatttttagcacactattcgaaaggataggccgcagagctta
gagtctacggtaatacatattggttactaagatcgtctggttgcacatttttgatgcaaccggacggtctttttttgttatataaatataaaaaa
taggagggaactatgcaaaggatcc 
Emboss analysis (http://www.ebi.ac.uk/Tools/es/cgi-bin/jobresults.cgi/needle/needle-
20100428-1516547298.html, 28/4-2010) revealed a single mutation. Complementary, 
reverse sequence was analyzed. 
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Original sequence; pCR II-TOPO-promoter of Bt407_1060 in Bt 407, 
complementary, reverse strand: 
ggatcctttgcatagttccctcctattttttatatttatataacaaaaaaagaccgtccggttgcatcaaaaatgtgcaaccagacgatcttag
taccaatatgtattaccgtagactctaagctttgcggcctatcctttcgaatagtgtgctaaaaatatcttttattcttttttttgtttcattttcctct
taaaccaaatattactataccgtctggacggttataattcaatactctataaaattgttctatttttctaataaaaaaaataattcacgactgcat
taaagaagcaatggtgaattattttcgcattatatagttcgtatattctatttatatgaattaccaataagagcttgaatcactttttctcttaactc
gggctgcag 
Obtained sequence, pCR II-TOPO-promoter of Bt407_0422 in Bt 407, 
S1_pUC19F: 
ggatcctttgcatagttccctcctattttttatatttatataacaaaaaaagaccgtccggttgcatcaaaaatgtgcaaccagacgatcttag
taaccaatatgtattaccgtagactctaagctctgcggcctatcctttcgaatagtgtgctaaaaatatcttttattcttttttttgtttcattttcct
cttaaaccaaatattactataccgtctggacggttataattcaatactctataaaattgttctatttttctaataaaaaaaataattcacgactgc
attaaagaagcaatggtgaattattttcgcattatatagttcgtatattctatttatatgaattaccaataagagcttgaatcactttttctcttaac
tcgggctgcag 
Emboss analysis (http://www.ebi.ac.uk/Tools/es/cgi-bin/jobresults.cgi/needle/needle-
20100428-1519535130.html, 28/4-2010) revealed the same mutation on the complementary 
strain. 
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Appendix 3: Sequence analysis of PCR product of 
promBt407_1060 from Bt407 template (11-11-2009):  
 
Original sequence; promBt407_1060 from Bt 407, forward direction*: 
ctgcagcccgagttaagagaaaaagtgattcaagctcttattggtaattcatataaatagaatatacgaactatataatgcgaaaataattc
accattgcttctttaatgcagtcgtgaattattttttttattagaaaaatagaacaattttatagagtattgaattataaccgtccagacggtata
gtaatatttggtttaagaggaaaatgaaacaaaaaaaagaataaaagatatttttagcacactattcgaaaggataggccgcaaagctta
gagtctacggtaatacatattggttactaagatcgtctggttgcacatttttgatgcaaccggacggtctttttttgttatataaatataaaaaa
taggagggaactatgcaaaggatcc 
Obtained sequence; promBt407_1060 from Bt 407, S2_pUC19R:  
atagagtattgaattataaccgtccagacggtatagtaatatttggtttaagaggaaaatgaaacaaaaaaaagaataaaagatatttttag
cacactattcgaaaggataggccgcaaagcttagagtctacggtaatacatattggttactaagatcgtctggttgcacatttttgatgcaa
ccggacggtctttttttgttatataaatataaaaaata 
Analysis of the marked region showed no sign of the mutation previously discovered.  
Original sequence; promBt407_1060 from Bt 407, complementary, reverse 
strand*: 
ggatcctttgcatagttccctcctattttttatatttatataacaaaaaaagaccgtccggttgcatcaaaaatgtgcaaccagacgatcttag
taaccaatatgtattaccgtagactctaagctttgcggcctatcctttcgaatagtgtgctaaaaatatcttttattcttttttttgtttcattttcct
cttaaaccaaatattactataccgtctggacggttataattcaatactctataaaattgttctatttttctaataaaaaaaataattcacgactgc
attaaagaagcaatggtgaattattttcgcattatatagttcgtatattctatttatatgaattaccaataagagcttgaatcactttttctcttaac
tcgggctgcag 
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Obtained sequence, promBt407_1060 from Bt 407, S1_pUC19F: 
Gacgatcttagtaaccaatatgtattaccgtagactctaagctttgcggcctatcctttcgaatagtgtgctaaaaatatcttttattctttttttt
gtttcattttcctcttaaaccaaatattactataccgtctggacggttataattcaatactctataaaattgttctatttttctaataaaaaaaataa
ttcacgactgcattaaagaagcaatggt 
Analysis of the marked region showed no sign of the mutation on the complementary strain.  
*Marked area show extent of generated sequence.   
Appendix 4: Sequence analysis of Bt407_0422 - pHT304-
pXyl construct (8/1-2010) 
Original sequence Bt407_0422 - pHT304-pXyl (forward):  
 
TAAGGAAGGTGGATATTAATGAAAAAATATTGGCATAAGTTATCGTTCCTTCAAAAGAACGTCTT
ATTAACCGTATTAGTTATTTTGACACTTGTTGGAAGTATGGGTGCACTAAGTTTCAACATGTTTCA
AAATAGTATGATGTCTTTATTTGAAAGGCAGTCTATTGAAACAGGAGAAATAGTATTGAAAAAAT
TGGATGTAGAATTAGTTAGAGACATGGCGAAAGATCCTACAGCCGAAAAAGTGAAAAAAGAAAA
GTTAACAGAGAAATTAGATGAAGTGTCAAAAGAATTGAAAAGTGTTGGACAAACGTATGTTACAG
GAGCAAAGCCGAATGAAAAGCGAGAATTACAACTCGTTGGTTTGACTACAGAGTTAACAAAAGCG
TTCCCTATAAAGCCGGGAGATTATTATGAACAACCCGCTCATTGGATGAAGGCATACGATAAAGT
CATTGATACGAAAAAGGCCCAAATGACAGAAGTATATGAAGATGAAATAGGTTCGTGGGTGACAA
TATTAGAACCAATTACAGATGGAGAAAACAATATTGTTGCAATTATTGCGGCTGACTTAGATGCTT
CCATTGTTCCTATTACAAAAGAGAAGTTTATGATACAGGGCTTACTCTTTATCATTATTTCATTAGC
GATTGCGACTATTACTCAATTCTTTATCGTGCGTCACTCATTAGCGCCATTAAAAGATTTACGAGA
AGGGTTACGTAAAATTGGTGAAGGTGACTTGAGTATTAAATTAAAAGAAAGACCAGATGATATTG
GAATTATTAATGTTTATTTCAATAACACGATTGAAAAGTTTAAAGGGATTATAGATAAAGTAAGG
CAAACTGCTGAGCAAGTTTCTTCTTCTTCACAAGAATTGTCGGCGAGTACAGAGGAAAACAGCAT
GGCAGTTCAAGAGATTGCAAGTTCTATTGAAGGTTTAAGAGTAGGGGCACAGTCTCAAAAAACTT
CAGTACAACAATGTTTAGG+GATTGTACATGGAATGGAAGATAAGGTAGAAGAGATAACTGGGGC
TGCGAAACAAGTTGCGGTTGCTTCTGAAGGTATGGAGCAACATTCAATTGAAGGTAATGAAGTGA
TTGGACAAATTATTAATCAAATGAGTTTAATTCAAAATGCAGTACAAGATTTATCTTCCATCATTT
ATTCGTTAGAAACAAGGTCAAAAGAAATTAGTGATATCGTAACTGTAATTACAGGTATTTCAAATC
AAACAAATTTATTAGCTTTAAATGCTTCTATTGAGGCTTCACGTGCTGGAGCAGCGGGGAGAGGG
TTTGCAGTTGTTGCTGATGAAGTACGAAAATTAGCAGAACAAACGGAAGCGTCTGCTAAAGATAT 
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AGCGAAATTAATTGGTGAAACACAAGCTGAGACAGAAGATGCTGTAGTTTCAATGCAAAAAGGTT
CAAAAGAAGTAGAAACTGGAATTTCACTTGTTCAAAGTAGTGGGAATTTCTTTGAAAAAATCTCC
AAATCAGCGCAATCTGTTACAGATCAAGTAAAAGCTGTTTCGGGTAATTCGAGTGACATTTTACAA
AATAGCCAGAATATCGTTCAAGTCGTAAATGAATTATCACATATTGCAAACACTTATGCCAACAGC
AGTAGTAATGTTGAAGAAAGCATGAAAGAGCAAGAAATATCAGTACAAGATATTGCAGAATTAGC
GACTTCTTTAAGTTGGCTTTCTCAGGAATTACAAGAGCTTATTGGTGAGTTTAAAAGCGAATAAGG
AGAAAGTTCAATTCTAATCAAAGGGGATATCTCC 
 
Original sequence Bt407_0422 - pHT304-pXyl (reverse, complementary):  
 
GGAGATATCCCCTTTGATTAGAATTGAACTTTCTCCTTATTCGCTTTTAAACTCACCAATAAGCTCT
TGTAATTCCTGAGAAAGCCAACTTAAAGAAGTCGCTAATTCTGCAATATCTTGTACTGATATTTCT
TGCTCTTTCATGCTTTCTTCAACATTACTACTGCTGTTGGCATAAGTGTTTGCAATATGTGATAATT
CATTTACGACTTGAACGATATTCTGGCTATTTTGTAAAATGTCACTCGAATTACCCGAAACAGCTT
TTACTTGATCTGTAACAGATTGCGCTGATTTGGAGATTTTTTCAAAGAAATTCCCACTACTTTGAA
CAAGTGAAATTCCAGTTTCTACTTCTTTTGAACCTTTTTGCATTGAAACTACAGCATCTTCTGTCTC
AGCTTGTGTTTCACCAATTAATTTCGCTATATCTTTAGCAGACGCTTCCGTTTGTTCTGCTAATTTT
CGTACTTCATCAGCAACAACTGCAAACCCTCTCCCCGCTGCTCCAGCACGTGAAGCCTCAATAGAA
GCATTTAAAGCTAATAAATTTGTTTGATTTGAAATACCTGTAATTACAGTTACGATATCACTAATT
TCTTTTGACCTTGTTTCTAACGAATAAATGATGGAAGATAAATCTTGTACTGCATTTTGAATTAAA
CTCATTTGATTAATAATTTGTCCAATCACTTCATTACCTTCAATTGAATGTTGCTCCATACCTTCAG
AAGCAACCGCAACTTGTTTCGCAGCCCCAGTTATCTCTTCTACCTTATCTTCCATTCCATGTACAAT
CCCTAAACATTGTTGTACTGAAGTTTTTTGAGACTGTGCCCCTACTCTTAAACCTTCAATAGAACTT
GCAATCTCTTGAACTGCCATGCTGTTTTCCTCTGTACTCGCCGACAATTCTTGTGAAGAAGAAGAA
ACTTGCTCAGCAGTTTGCCTTACTTTATCTATAATCCCTTTAAACTTTTCAATCGTGTTATTGAAAT
AAACATTAATAATTCCAATATCATCTGGTCTTTCTTTTAATTTAATACTCAAGTCACCTTCACCAAT
TTTACGTAACCCTTCTCGTAAATCTTTTAATGGCGCTAATGAGTGACGCACGATAAAGAATTGAGT
AATAGTCGCAATCGCTAATGAAATAATGATAAAGAGTAAGCCCTGTATCATAAACTTCTCTTTTGT
AATAGGAACAATGGAAGCATCTAAGTCAGCCGCAATAATTGCAACAATATTGTTTTCTCCATCTGT
AATTGGTTCTAATATTGTCACCCACGAACCTATTTCATCTTCATATACTTCTGTCATTTGGGCCTTT
TTCGTATCAATGACTTTATCGTATGCCTTCATCCAATGAGCGGGTTGTTCATAATAATCTCCCGGCT
TTATAGGGAACGCTTTTGTTAACTCTGTAGTCAAACCAACGAGTTGTAATTCTCGCTTTTCATTCG
GCTTTGCTCCTGTAACATACGTTTGTCCAACACTTTTCAATTCTTTTGACACTTCATCTAATTTCTC
TGTTAACTTTTCTTTTTTCACTTTTTCGGCTGTAGGATCTTTCGCCATGTCTCTAACTAATTCTACAT
CCAATTTTTTCAATACTATTTCTCCTGTTTCAATAGACTGCCTTTCAAATAAAGACATCATACTATT 
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TTGAAACATGTTGAAACTTAGTGCACCCATACTTCCAACAAGTGTCAAAATAACTAATACGGTTAA
TAAGACGTTCTTTTGAAGGAACGATAACTTATGCCAATATTTTTTCATTAATATCCACCTTCCTTA 
 
Obtained sequence Bt407_0422 with pHT304-pXyl_forward:  
 
CCTTTATTATATCTAATGTGTTCATAAAAAACTAAAAAAAATATTGAAAATACTGACGAGGTTATA
TAAGATGAAAATAAGTTAGTTTGTTTAAACAACAAACTAATAGGTGATGTACTTACTATATGAAAT
AAAATGCATCTGTATTTGAATGAATTTATTTTTAAGGGGGAAATCMCATGGCTCAATCTAGATTAA
GGAAGGTGGATATTAATGAAA 
Obtained sequence Bt407_0422 with 00330-Bt407_0422-F2:  
 
GAAGTATATGAAGATGAAATAGGTTCGTGGGTGACAATATTAGAACCAATTACAGATGGAGAAAA
CAATATTGTTGCAATTATTGCGGCTGACTTAGATGCTTCCATTGTTCCTATTACAAAAGAGAAGTT
TATGATACAGGGCTTACTCTTTATCATTATTTCATTAGCGATTGCGACTATTACTCAATTCTTTATC
GTGCGTCACTCATTAGCGCCATTAAAAGATTTACGAGAAGGGTTACGTAAAATTGGTGAAGGTGA
CTTGAGTATTAAATTAAAAGAAAGACCAGATGATATTGGAATTATTAATGTTTATTTCAATAACAC
GATTGAAAAGTTTAAAGGGATTATAGATAAAGTAAGGCAAACTGCTGAGCAAGTTTCTTCTTCTTC
ACAAGAATTGTCGGCGAGTACAGAGGAAAACAGCATGGCAGTTCAAGAGATTGCAAGTTCTATTG
AAGGTTTAAGAGTAGGGGCACAGTCTCAAAAAACTTCAGTACAACAATGTTTAGGGATTGTACAT
GGAATGGAAGATAAGGTAGAAGAGATAACTGGGGCTGCGAAACAAGTTGCGGTTGCTTCTGAAG
GTATGGAGCAACATTCAATTGAAGGTAATGAAGTGATTGGACAAATTATTAATCAAATGAGTTTA
ATTCAAAATGCAGTACAAGATTTATCTTCCATCATTTATTCGTTAGAAACAAGGTCAAAAGAAATT
AGTGATATCGTAACTGTAATTACAGGTATTTCAAATCAAACAAATTTATTAGCTTTAAATGCTTCT
ATTGAGGCTTCACGTGCTGGAGCAGCGGGGAGAGGGTTTGCAGTTGTTGCTGATGAAGTACGAAA
ATTAGCAGA 
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Obtained sequence Bt407_0422 with 00330-Bt407_0422-R2:  
 
ATGACTTTATCGTATGCCTTCATCCAATGAGCGGGTTGTTCATAATAATCTCCCGGCTTTATAGGG
AACGCTTTTGTTAACTCTGTAGTCAAACCAACGAGTTGTAATTCTCGCTTTTCATTCGGCTTTGCTC
CTGTAACATACGTTTGTCCAACACTTTTCAATTCTTTTGACACTTCATCTAATTTCTCTGTTAACTT
TTCTTTTTTCACTTTTTCGGCTGTAGGATCTTTCGCCATGTCTCTAACTAATTCTACATCCAATTTTT
TCAATACTATTTCTCCTGTTTCAATAGACTGCCTTTCAAATAAAGACATCATACTATTTTGAAACAT
GTTGAAACTTAGTGCACCCATACTTCCAACAAGTGTCAAAATAACTAATACGGTTAATAAGACGTT
CTTTTGAAGGAACGATAACTTATGCCAATATTTTTTCATTAATATCCACCTTCCTTAATCTAGATTG
AGCCATGTGATTTCCCCCTTAAAAATAAATTCATTCAAATACAGATGCATTTTATTTCATATAGTA
AGTACATCACCTATTAGTTTGTTGTTTAAACAAACTAACTTATTTTCATCTTATATAACCTCGTCAG
TATTTTCAATATTTTTTTTAGTTTTTTATGAACACATTAGATATAATAAAGGGAAGATTCGCTATGT
ACTATGTTGATACTTAATTTAAAGATTAAACAAATGGAGTGGATGAAGTGGATATCGCTGATCAA
ACCTTTGTCAAAAAAGTAAATCAAAAGTTATTATTAAAAGAAATCCTTAAAATTCACCTATTTCAA
GAGCAAAATTATCTGAAATGACTGGATTAAATAAATCAACTGTCTCATCACAGGTAAACACGTTA
ATGAAAGAAAGTATGGTATTTGAAATAGTCAAGGACAATCAAGTGGCGGAAGAGACCTGTCATGC
TTGTTTTAATAAAAAGCAGATACTCCGTTGGAATAGATGTTGGTGTGATATATAATGGCATTTACA
GACCT 
 
Obtained sequence Bt407_0422 with S2_pUC19R: 
 
TGAACTTTCTCCTTATTCGCTTTTAAACTCACCAATAAGCTCTTGTAATTCCTGAGAAAGCCAACTT
AAAGAAGTCGCTAATTCTGCAATATCTTGTACTGATATTTCTTGCTCTTTCATGCTTCCTTCAACAT
TACTACTGCTGTTGGCATAAGTGTTTGCAATATGTGATAATTCATTTACGACTTGAACGATATTCT
GGCTATTTTGTAAAATGTCACTCGAATTACCCGAAACAGCTTTTACTTGATCTGTAACAGATTGCG
CTGATTTGGAGACTTTTTCAAAGAAATTCCCACTACTTTGAACAAGTGAAATTCCAGTTTCTACTT
CTTTTGAACCTTTTTGCATTGAAACTACAGCATCTTCTGTCTCAGCTTGTGTTTCACCAATTAATTT
CGCTATATCTTTAGCAGACGCTTCCGTTTGTTCTGCTAATTTTCGTACTTCATCAGCAACAACTGCA
AACCCTCTCCCCGCTGCTCCAGCACGTGAAGCCTCAATAGAAGCATTTAAAGCTAATAAATTTGTT
TGATTTGAAATACCTGTAATTACAGTTACGATATCACTAATTTCTTTTGACCTTGTTTCTAACGAAT 
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AAATGATGGAAGATAAATCTTGTACTGCATTTTGAATTAAACTCATTTGATTAATAATTTGTCCAA
TCACTTCATTACCTTCAATTGAATGTTGCTCCATACCTTCAGAAGCAACCGCAACTTGTTTCGCAG
CCCCAGTTATCTCTTCTACCTTATCTTCCATTCCATGTACAATCCCTAAACATTGTTGTACTGAAGT
TTTTTGAGACTGTGCCCCTACTCTTAAACCTTCAATAGAACTTGCAATCTCTTGAACTGCCATGCTG
TTTTCCTCTGTACTCGCCGACAATTCTTGTGAAAAGAAGAAACTTGCTCAGCAGTTTGCCTTACTTT
ATCTATAATCCCTTTAAACTTTTCAATCGTGTTATTGAAATAAACATTATAATTCCATATCATCTGG
TCTTTCTTTTAATTTAATACTCAGTC 
Analysis of the obtained sequences with the original sequence showed two mutations 
(marked red).   
Appendix 5: Sequence analysis after first mutagenesis 
(28/1-2010) 
 
Original sequence Bt407_0422: 
tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatctt
gtactgatatttcttgctctttcatgctttcttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaaa
gaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcat 
Obtained sequence Bt407_0422 colony 1:  
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgcttccttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagactttttcaa
agaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcat 
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Obtained sequence Bt407_0422 colony 2:  
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgcttccttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagactttttcaa
agaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcat 
Obtained sequence Bt407_0422 colony 3:  
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgcttccttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaaa
gaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcattgaaactacagcatcttctgtctcagcttgtgtt
tcaccaattaatttcgctatatctttagcagacgcttccgtttg 
Obtained sequence Bt407_0422 colony 4:  
tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatctt
gtactgatatttcttgctctttcatgcttccttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaaa
gaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcattgaaac 
Obtained sequence Bt407_0422 colony 5:  
tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatctt
gtactgatatttcttgctctttcatgcttccttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagactttttcaa
agaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcattgaaa 
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Obtained sequence Bt407_0422 colony 6:  
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgcttccttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaaa
gaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcattgaaactacagcatcttctgtctcagcttgtgtt
tcaccaattaatttcgctatatctttagcagacgcttcc 
Colony 3, 4 and 6 did not contain the original mutation. 
Appendix 6: Sequence analysis after second mutagenesis 
(3/2-2010) 
 
Original sequence Bt407_0422: 
 
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgctttcttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaaa
gaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcat 
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Obtained sequence Bt407_0422 colony 1: 
 
Not generated, error done by the DNA sequence lab. 
 
Obtained sequence Bt407_0422 colony 2: 
 
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgctttcttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaaa
gaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcattgaaactaca 
 
Obtained sequence Bt407_0422 colony 3: 
 
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgcttccttcaacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaac
gatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaaa
gaaattcccactactttgaacaagtgaaattccagtttctacttcttttgaacctttttgcattgaaactac 
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Obtained sequence Bt407_0422 colony 4: 
 
Tgaactttctccttattcgcttttaaactcaccaataagctcttgtaattcctgagaaagccaacttaaagaagtcgctaattctgcaatatct
tgtactgatatttcttgctctttcatgctttcttcmacattactactgctgttggcataagtgtttgcaatatgtgataattcatttacgacttgaa
cgatattctggctattttgtaaaatgtcactcgaattacccgaaacagcttttacttgatctgtaacagattgcgctgatttggagattttttcaa
agaaat 
 
Appendix 7: Protein sequence of Bt407_0422 and 
Bt407_1060 in Bt 407 
 
Bt407_0422: 
 
MKKYWHKLSFLQKNVLLTVLVILTLVGSMGALSFNMFQNSMMSLFERQSIETGEIVLKKLDVELVRD
MAKDPTAEKVKKEKLTEKLDEVSKELKSVGQTYVTGAKPNEKRELQLVGLTTELTKAFPIKPGDYYE
QPAHWMKAYDKVIDTKKAQMTEVYEDEIGSWVTILEPITDGENNIVAIIAADLDASIVPITKEKFMIQG
LLFIIISLAIATITQFFIVRHSLAPLKDLREGLRKIGEGDLSIKLKERPDDIGIINVYFNNTIEKFKGIIDKVR
QTAEQVSSSSQELSASTEENSMAVQEIASSIEGLRVGAQSQKTSVQQCLGIVHGMEDKVEEITGAAKQV
AVASEGMEQHSIEGNEVIGQIINQMSLIQNAVQDLSSIIYSLETRSKEISDIVTVITGISNQTNLLALNASIE
ASRAGAAGRGFAVVADEVRKLAEQTEASAKDIAKLIGETQAETEDAVVSMQKGSKEVETGISLVQSSG
NFFEKISKSAQSVTDQVKAVSGNSSDILQNSQNIVQVVNELSHIANTYANSSSNVEESMKEQEISVQDIA
ELATSLSWLSQELQELIGEFKSE 
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Bt407_1060:  
MKSTKRHISMVSLVFLVLFSVLNVWAPVIQAAVMKSPVDEINISRTDGTTSEPYQASDGMKVEVKWS
AKEKIKSGDQFTIDMPKEFRKDLMNMSFPLKDAEGKTVGTCEMKKGLLTCTMGNYVEGKNNIKGSLF
VEFYFGLEAYDGVKEIPLEFNVDGQIVNKEVNVSNTTERPKPQPNTDNLLKWGSYNQEDPSIADWLVY
VNATGTEMQDLKLTDTLGPGHELITDSVVLEEAVFEDGYAPTNIKPADLSNIKINATKTGFTIEFPDSSK
GYILRYKTKVTNPAAKPHKNTVKLEGKNIKTEEKVGQVFVSGGGGSGSGDNNPPSIEKNIVDENGKLV
ENEQLTQMDQVIQYQVGTHIPNDPPKYTSMVISDDLEDVLEVLEAKVYDQNGQDITSKGTLNIDKQRS
EVTFTFGESFDYKSYEDQIINLSIKAKIKNNADLSSYVDKKIPNKAELHFDDKTLTSKEVTITPPEAPKDG
TVSLHKIDSENPNKGLKAAEFEVRNSANEVVAKLKTDEKGFSVPQTLAPGTYKVYETVAPEGYQKLTS
PVEVTLQAGETKTIEIKNTMQKGQIEVKKIDSENGEKPLANAEFDIVKDGVVVEHIVTDKDGKAISKPL
APGKYILKETKAPEGYQLKETEFEVNVTGDGIFPIQVENAMVDKGNIEITKVDKENGAVLAGVEFEVQ
DEKDGVVRKVVTDKEGKANVSDLSVGKYKLVETKSLPGYKNLAEPVLFEITKGMTKALVIKVENEQL
DKGSVEITKIDKDSQKVLEGVVFEVQDEQGKVVTEVKTDKDGKAKISDLSVGKYKLVETKSLPGYKK
LTEPVSFEITKGMTTVLSLKVENEQLDKGSVEITKVDKDSKKALKGVVFEVQDEAGTVVKEVKTDKD
GKAKISDLLVGKYKLVEKESLPGYKKLTDPVLFEIKKGMTKVLSLKIENEMVDTGNVEITKIDKDNKA
PLAGVTFIVQDEKGNEVTKVTTDKDGKANVSDLPVGKYELVEVESLPGYKKLEKPVSFEIKKGMTEV
LSLKVENEMVDTGNVEITKIDKDSKAPLENVVFEVRDLKGKVVAKVTTDKEGKANVSDLPIGKYELV
EVETPAGYKPLEKPISFEIEKGRVTALKLTVENELVDTGNVEITKVDKENKDALADAVFEIQDEAGQVV
AKITTDKKGQAQVTNLSVSTYKLVEVKAPKGYKQLVDPITFQIEKGMTKSLALTVENEMLDKGNVEV
TKVDKDSQKVLEGVVFEVQDDKGKVVTEVTTDKEGKANVSDLSVGKYKLVETKSLPGYKKLTEPVS
FEIKKGMTKVLSLKVENEQLDKGSVEITKVDKESGAVLAGVTFEVQDEKDKVVTKVKTDKEGKANVS
DLSVGKYKLVEVESLPGYKKLAKPVSFEIKKGMTEVLSLKVENEQLDKGSVEITKVDKDSQKALEGVT
FEVQDEKGKVVTKVTTDKEGKVKISDLSVGSYKLVEVENLPGYKKLTEPVSFEIKKGMTEVLSLKVEN
EQLDKGSVEITKVDKDSQKVLEGVVFEVQDEQGKVVTEVKTDKNGKAKISDLSVGKYKLVEKESLPG
YKKLTEPVSFEIKKGMTEVLSLKIENEMVDTGNVEITKIDKDNKAPLAGVVFEVQDDKGKVVTKVTT
DKAGKATVSDLSVGKYKLVEVDSLPGYKKLEKPVPFEIKKGMTKSLTFTVENEMVDTGNVEITKIDK
DSKARLENVVFEVRDSKGKVVAKVTTDKEGKANVSDLSIGKYELVEVETPAGYKPLEKPVSFEIEKGR
VTALQLTVENELVDTGNIEITKVDKENKDALADAVFEIQDAAGQVVAKITTDKKGQAQVTNLSVGTY
KLVEVKAPKGYKQLVDPITFQIEKGMTKSLALTVENEMLDKGNVEVTKVDKDSQKVLEGVVFEVQD
EQGKVVTEVTTDKEGKANVSDLSVGKYKLVETKSLPGYKKLTEPVSFEIKKGMTKVLSLKVENEQLD
KGSVEITKMAAESKEVLSGAVFEVHDEKGKVVVKVTTDKGGKAKIADLSVGNYTLVEVEAPKGYEK
LTNPIPFEITNGMINAVQLEVLNKLNHLAPPGPETPDPEKPGTPDPEKPGTPDPEKPGTPNPEKPGTPDP 
EKPGTPNPEKPGTPDPEKPGTPNPEKPGTPDPEKPGTPNPEKPGTPNPEKSEKELPKTGQKMPVEPYMG
ALLVMMSFGLFVLGRKQQR 
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